EX-1.1 FORM OF UNDERWRITING AGREEMENT

Exhibit 1.1



ATA INC.
(an exempted company limited by shares
under the laws of the Cayman Islands)

[-] American Depositary Shares
each representing two Common Shares

FORM OF UNDERWRITING AGREEMENT

[-], 2008

Merrill Lynch, Pierce, Fenner & Smith
Incorporated
as Representative of the several Underwriters
4 World Financial Center
250 Vesey Street
New York, New York 10080

Ladies and Gentlemen:

ATA Inc., an exempted company limited by shares under the laws of the
Cayman Islands (the "Company"), confirms its agreement with Merrill Lynch,
Pierce, Fenner & Smith Incorporated ("Merrill Lynch") and each of the other
underwriters named in Schedule A hereto (collectively, the "Underwriters," which
term shall also include any underwriter substituted as hereinafter provided in
Section 10 hereof) for whom Merrill Lynch is acting as representative (in such
capacity, the "Representative"), with respect to (i) the issue and sale by the
Company, and the purchase by the Underwriters, acting severally and not jointly,
of the respective numbers of American Depositary Shares ("ADSs"), each ADS
representing two common shares, par value US$0.01 per share, of the Company
("Common Shares"), set forth in Schedule A hereto and (ii) the grant by the
Company to the Underwriters, acting severally and not jointly, of the option
described in Section 2(b) hereof for the Underwriters to purchase all or any
part of [-] additional ADSs, to cover over-allotments, if any. The aforesaid [-]
ADSs (the "Initial Securities") to be purchased by the Underwriters and all or
any part of the [-] ADSs subject to the option described in Section 2(b) hereof
(the "Option Securities") are hereinafter called, collectively, the
"Securities." The offer of the Securities by the Underwriters is hereinafter
called the "Offering."

The Common Shares to be represented by ADSs are to be deposited pursuant to
a deposit agreement (the "Deposit Agreement"), among the Company, Citibank,
N.A., as depositary (the "Depositary"), and the holders from time to time of the
American Depositary Receipts ("ADRs") to be issued under the Deposit Agreement
and evidencing the ADSs.

Unless the context otherwise requires, references to the "Securities"
herein shall constitute references both to the Common Shares and to the ADSs
(and to the Common Shares represented by such ADSs). All references to "US
dollars" or "$" herein are to United States dollars.


The Company understands that the Underwriters propose to make a public
offering of the Securities as soon as the Representative deems advisable after
this Agreement has been executed and delivered.

The Company hereby acknowledges that, as part of the proposed offering of
the ADSs, it has requested Piper Jaffray & Co. to administer a directed share
program (the "Directed Share Program") under which up to [-] ADSs, or 8% of the
ADSs to be purchased by the Underwriters (the "Reserved Securities"), shall be
reserved for sale by the Underwriters at the purchase price set forth on the
cover page of the Prospectus (as defined below) to certain eligible friends and
family members of the Company's management, directors, affiliates and strategic
partners of the Company and employees of certain of the Company's clients,
course content providers and landlord (collectively, the "Directed Share
Participants"), as part of the distribution of the Securities by the
Underwriters, subject to the terms of this Agreement, the applicable rules,
regulations and interpretations of the Financial Industry Regulatory Authority
("FINRA"), formerly known as the National Association of Securities Dealers,
Inc., and all other applicable laws, rules and regulations. To the extent that
such Reserved Securities are not orally confirmed for purchase by such Directed
Share Participants by the end of the first business day after the date of this
Agreement, such Reserved Securities may be offered to the public as part of the
public offering contemplated hereby. The Company has supplied Piper Jaffray &
Co. with the names, addresses and telephone numbers of the individuals or other
entities which the Company has designated to be the Directed Share Participants.

The Company has filed with the Securities and Exchange Commission (the
"Commission") a registration statement on Form F-1 (No. 333-148512) covering the
registration of the Securities under the Securities Act of 1933, as amended (the
"1933 Act"), including the related preliminary prospectus or prospectuses.
Promptly after execution and delivery of this Agreement, the Company will
prepare and file a prospectus in accordance with the provisions of Rule 430A
("Rule 430A") of the rules and regulations of the Commission under the 1933 Act
(the "1933 Act Regulations") and paragraph (b) of Rule 424 ("Rule 424(b)") of
the 1933 Act Regulations. The information included in such prospectus that was
omitted from such registration statement at the time it became effective but
that is deemed to be part of such registration statement at the time it became
effective pursuant to paragraph (b) of Rule 430A is referred to as "Rule 430A
Information." Each prospectus filed with the Commission used before such
registration statement became effective, and any prospectus filed with the
Commission that omitted the Rule 430A Information that was used after such
effectiveness and prior to the execution and delivery of this Agreement is
called a "preliminary prospectus." Such registration statement, including the
amendments, exhibits and schedules thereto, if any, at the time it became
effective and including the Rule 430A Information is herein called the
"Registration Statement." Any registration statement filed pursuant to Rule
462(b) of the 1933 Act Regulations is herein referred to as the "Rule 462(b)
Registration Statement," and after such filing the term "Registration Statement"
shall include the Rule 462(b) Registration Statement. The final prospectus in
the form first furnished to the Underwriters for use in connection with the
Offering is herein called the "Prospectus." For purposes of this Agreement, all
references to the Registration Statement, any preliminary prospectus, the
Prospectus or any amendment or supplement to any of the foregoing shall be
deemed to include the copy filed with the Commission pursuant to its Electronic
Data Gathering, Analysis and Retrieval system ("EDGAR").

2

All references in this Agreement to financial statements and schedules and
other information which is "contained," "included" or "stated" in the
Registration Statement, any preliminary prospectus or the Prospectus (or other
references of like import) shall be deemed to mean and include all such
financial statements and schedules and other information which is incorporated
by reference in or otherwise deemed by 1933 Act Regulations to be a part of or
included in the Registration Statement, any preliminary prospectus or the
Prospectus, as the case may be; and all references in this Agreement to
amendments or supplements to the Registration Statement, any preliminary
prospectus or the Prospectus shall be deemed to mean and include any document
filed under the Securities Exchange Act of 1934 (the "1934 Act") which is
incorporated by reference in or otherwise deemed by 1933 Act Regulations to be a
part of or included in the Registration Statement, such preliminary prospectus
or the Prospectus, as the case may be.

The Company and the Depositary have prepared and filed with the Commission
a registration statement on Form F-6 (No. 333-148641) and a related prospectus,
which may be in the form of the ADR certificate, for the registration under the
1933 Act of the ADSs evidenced by ADRs, have filed such amendments thereto and
such amended preliminary prospectuses as may have been required to the date
hereof, and will file such additional amendments thereto and such amended
prospectuses as may hereafter be required. The registration statement on Form
F-6 for the registration of the ADSs evidenced by ADRs, as amended at the time
it becomes effective (including by the filing of any post-effective amendments
thereto), is hereinafter called the "ADR Registration Statement."

The Company has prepared and filed with the Commission a registration
statement on Form 8-A (No. 001-33910) for the registration under the 1934 Act of
the Common Shares. The various parts of such registration statement on Form 8-A
for the registration of the Common Shares, including all exhibits thereto, each
as amended at the time such part of the registration statement became effective,
are hereinafter called the "Form 8-A Registration Statement."

SECTION 1. Representations and Warranties.

(a) Representations and Warranties by the Company. The Company represents
and warrants to each Underwriter as of the date hereof, as of the Applicable
Time referred to in Section 1(a)(i) hereof, as of the Closing Time referred to
in Section 2(d) hereof, and as of each Date of Delivery (if any) referred to in
Section 2(d) hereof, and agrees with each Underwriter, as follows:

(i) Compliance with Registration Requirements. Each of the
Registration Statement, any Rule 462(b) Registration Statement and any
post-effective amendment thereto, the ADR Registration Statement and the
Form 8-A Registration Statement has been declared effective by the
Commission under the 1933 Act or 1934 Act, as applicable, and no stop order
suspending the effectiveness of the Registration Statement, any Rule 462(b)
Registration Statement or any post-effective amendment thereto, the ADR
Registration Statement or the Form 8-A Registration Statement has been
issued under the 1933 Act or 1934 Act, as applicable, and no proceedings
for that purpose have been instituted or are pending or, to the knowledge
of the Company, are contemplated by the Commission, and any request on the
part of the Commission for additional information has been complied with.

3


At the respective times the Registration Statement, any Rule 462(b)
Registration Statement and any post-effective amendments thereto became
effective and at the Closing Time (and, if any Option Securities are
purchased, at the relevant Date of Delivery), the Registration Statement,
the Rule 462(b) Registration Statement and any amendments and supplements
thereto complied and will comply in all material respects with the
requirements of the 1933 Act and the 1933 Act Regulations and did not and
will not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the
statements therein not misleading, and the Prospectus, any preliminary
prospectus and any supplement thereto or prospectus wrapper prepared in
connection therewith, at their respective times of issuance and at the
Closing Time, complied and will comply in all material respects with any
applicable laws or regulations of foreign jurisdictions in which the
Prospectus and such preliminary prospectus, as amended or supplemented, if
applicable, are distributed in connection with the offer and sale of
Reserved Securities. Neither the Prospectus nor any amendments or
supplements thereto (including any prospectus wrapper), at the time the
Prospectus or any amendments or supplements thereto were issued and at the
Closing Time (and, if any Option Securities are purchased, at the relevant
Date of Delivery), included or will include an untrue statement of a
material fact or omitted or will omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances
under which they were made, not misleading.

As of the Applicable Time (as defined below), neither (x) the Issuer
General Use Free Writing Prospectus(es) (as defined below) issued at or
prior to the Applicable Time and the Statutory Prospectus (as defined
below) as of the Applicable Time and the information included on Schedule C
hereto, all considered together (collectively, the "General Disclosure
Package"), nor (y) any individual Issuer Limited Use Free Writing
Prospectus, when considered together with the General Disclosure Package,
included any untrue statement of a material fact or omitted to state any
material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading.

As used in this subsection and elsewhere in this Agreement:

"Applicable Time" means [-] p.m. (New York City time) on January [-],
2008 or such other time as agreed by the Company and the Representative.

"Statutory Prospectus" as of any time means the prospectus relating to
the Securities that is included in the Registration Statement immediately
prior to that time, including any document incorporated by reference
therein.

"Issuer Free Writing Prospectus" means any "issuer free writing
prospectus," as defined in Rule 433 of the 1933 Act Regulations ("Rule
433"), relating to the Securities that (i) is required to be filed with the
Commission by the Company, (ii) is a "road show that is a written
communication" within the meaning of Rule 433(d)(8)(i) whether or not
required to be filed with the Commission or (iii) is exempt from filing
pursuant to Rule 433(d)(5)(i) because it contains a description of the
Securities or of the offering that does not reflect the final terms, in
each case in the form filed or required to be filed with the

4


Commission or, if not required to be filed, in the form retained in the
Company's records pursuant to Rule 433(g).

"Issuer General Use Free Writing Prospectus" means any Issuer Free
Writing Prospectus that is intended for general distribution to prospective
investors (other than a Bona Fide Electronic Road Show (as defined below)),
as evidenced by its being specified in Schedule D hereto.

"Issuer Limited Use Free Writing Prospectus" means any Issuer Free
Writing Prospectus that is not an Issuer General Use Free Writing
Prospectus.

The Company has made available a "bona fide electronic road show," as
defined in Rule 433, in compliance with Rule 433(d)(8)(ii) (the "Bona Fide
Electronic Road Show") such that no filing of any "road show" (as defined
in Rule 433(h)) is required in connection with the offering of the
Securities.

Each Issuer Free Writing Prospectus, as of its issue date and at all
subsequent times through the completion of the public offer and sale of the
Securities or until any earlier date that the Company notified or notifies
the Representative as described in the next sentence, did not, does not and
will not include any information that conflicted, conflicts or will
conflict with the information contained in the Registration Statement or
the Prospectus, and any preliminary prospectus or other prospectus deemed
to be a part thereof that has not been superseded or modified.

The representations and warranties in this subsection shall not apply
to statements in or omissions from the Registration Statement, the
Prospectus or any Issuer Free Writing Prospectus made in reliance upon and
in conformity with written information furnished to the Company by any
Underwriter through the Representative expressly for use therein.

Each preliminary prospectus (including the prospectus filed as part of
the Registration Statement as originally filed or as part of any amendment
thereto, or filed pursuant to Rule 424 under the 1933 Act) complied when so
filed in all material respects with the 1933 Act and the 1933 Act
Regulations and each preliminary prospectus and the Prospectus delivered to
the Underwriters for use in connection with the Offering was identical to
the electronically transmitted copies thereof filed with the Commission
pursuant to EDGAR, except to the extent permitted by Regulation S-T.

At the time the ADR Registration Statement became effective and at the
Closing Time (and, if any Option Securities are purchased, at the Date of
Delivery), the ADR Registration Statement complied and will comply in all
material respects with the requirements of the 1933 Act and the 1933 Act
Regulations and did not and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

At the time the Form 8-A Registration Statement became effective and
at the Closing Time (and, if any Option Securities are purchased, at the
Date of Delivery), the

5


Form 8-A Registration Statement complied and will comply in all material
respects with the requirements of the 1934 Act and the rules and
regulations of the Commission under the 1934 Act (the "1934 Act
Regulations") and did not and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

At the time of filing the Registration Statement, any 462(b)
Registration Statement and any post-effective amendments thereto, at the
earliest time thereafter that the Company or another offering participant
made a bona fide offer (within the meaning of Rule 164(h)(2) of the 1933
Act Regulations) of the Securities, the Company was not and, at the date
hereof, is not an "ineligible issuer," as defined in Rule 405 of the 1933
Act Regulations.

(ii) Foreign Private Issuer. The Company is a "foreign private issuer"
as defined in Rule 405 under the 1933 Act.

(iii) Independent Accountants. KPMG, who have audited the financial
statements (including the notes thereto) of the Company and its
subsidiaries that are included in the Registration Statement and the
Prospectus, and whose report appears in the Registration Statement and the
Prospectus, are an independent registered public accounting firm and are
independent as required by the 1933 Act and the 1933 Act Regulations.

(iv) Financial Statements. The financial statements included in the
General Disclosure Package and the Prospectus, together with the related
schedules and notes, present fairly the financial position of the Company
and its consolidated subsidiaries at the dates indicated and the statement
of operations, shareholders' equity and cash flows of the Company and its
consolidated subsidiaries for the periods specified; said financial
statements have been prepared in conformity with accounting principles
generally accepted in the United States ("US GAAP") applied on a consistent
basis throughout the periods involved. The supporting schedules, if any,
included in the Registration Statement present fairly in accordance with US
GAAP the information required to be stated therein. No other financial
statements or supporting schedules are required to be included in the
General Disclosure Package or the Prospectus by the 1933 Act or the 1933
Act Regulations. The selected financial data and the summary financial
information included in the General Disclosure Package and the Prospectus
present fairly the information shown therein and have been compiled on a
basis consistent with that of the audited financial statements included in
the Registration Statement.

(v) No Material Adverse Change in Business. Since the respective dates
as of which information is given in the Registration Statement, the General
Disclosure Package and the Prospectus, except as otherwise stated therein,
(i) there has been no material adverse change in the condition, financial
or otherwise, or in the earnings, business affairs or business prospects of
the Company and the Group Entities (as defined below) taken as a whole,
whether or not arising in the ordinary course of business (a "Material
Adverse Effect"), (ii) there have been no transactions entered into by the
Company and the

6


Group Entities, other than those in the ordinary course of business, that
are material with respect to the Company or any of the Group Entities taken
as a whole, (iii) there has been no dividend or distribution of any kind
declared, paid or made by the Company on any class of its share capital,
(iv) there has been no material adverse change in the share capital,
long-term indebtedness, consolidated net current assets or shareholders'
equity, consolidated net revenues or the total or per-share amounts of net
income of the Company and its Group Entities, and (v) there has been no
obligation, direct or contingent (including any off-balance sheet
obligations), incurred by the Company or any Group Entity, which is
material to the Company and the Group Entities taken as a whole.

(vi) Organization of the Company. The Company has been duly organized
and is validly existing under the laws of the Cayman Islands, and has the
legal right, power and authority (corporate and other) to own, lease and
operate its properties and to conduct its business as described in the
General Disclosure Package and the Prospectus and to enter into and perform
its obligations under this Agreement and the Deposit Agreement (together,
the "Principal Agreements"), and is duly qualified to transact business and
is in good standing, where applicable, in any jurisdiction in which it owns
or leases any properties or conducts any business except where the failure
to so qualify or be in good standing would not result in a Material Adverse
Effect. The Company's Second Amended and Restated Memorandum and Articles
of Association (the "Current Articles of Association"), and its Third
Amended and Restated Memorandum and Articles of Association (the "Amended
Articles of Association" and, together with the Current Articles of
Association, the "Articles of Association"), which will become effective
immediately upon the closing of the Offering, comply with the requirements
of Cayman Islands law. The Current Articles of Association are in full
force and effect. The Amended Articles of Association, upon their
effectiveness, will be in full force and effect.

(vii) Organization of Group Entities. Each of ATA Testing Authority
(Beijing) Limited ("ATA Testing") and ATA Learning (Beijing) Inc. ("ATA
Learning"), each a "significant subsidiary" of the Company (as such term is
defined in Rule 1-02 of Regulation S-X), ATA Testing Authority (Holdings)
Limited ("ATA BVI") and ATA Online Education Technology Limited ("ATA
Online"), a variable interest entity (each a "Group Entity" and,
collectively, the "Group Entities") has been duly organized and is validly
existing as a corporation in good standing, where applicable, under the
laws of the jurisdiction of its incorporation and has the legal right,
power and authority (corporate and other) to own, lease and operate its
properties, if any, and to conduct its business as described in the General
Disclosure Package and the Prospectus and is duly qualified to transact
business and is in good standing, where applicable, in any jurisdiction in
which it owns or leases any properties or conducts any business except
where the failure to so qualify or be in good standing would not result in
a Material Adverse Effect; except as otherwise disclosed in the General
Disclosure Package and the Prospectus, all of the issued and outstanding
share capital or equity interest of each of ATA Testing, ATA Learning and
ATA BVI has been duly authorized and validly issued, is fully paid and
non-assessable and is owned by the Company or, in the case of ATA Testing
and ATA Learning, by ATA BVI directly, free and clear of any security
interest, mortgage, pledge, lien, encumbrance, claim or equity; except as
otherwise disclosed in the General Disclosure Package and the Prospectus,
all of the equity interest of ATA Online has been

7


duly authorized and validly issued and is 100% owned, collectively, by Mr.
Kevin Xiaofeng Ma and Mr. Walter Lin Wan directly, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, claim or equity;
and none of the outstanding shares of equity interest of such Group Entity
was issued in violation of the preemptive or similar rights of any
securityholder of such Group Entity. Other than the Group Entities, the
Company does not own, directly or indirectly, any entity, and the Group
Entities constitute all of the entities that are consolidated in the
Company's financial statements included in the Registration Statement, the
General Disclosure Package and the Prospectus.

(viii) Capitalization. The authorized, issued and outstanding share
capital of the Company is as set forth in the General Disclosure Package
and the Prospectus in the column entitled "Actual" under the caption
"Capitalization" (except for subsequent issuances, if any, pursuant to this
Agreement or pursuant to reservations, agreements or employee benefit plans
referred to in the Prospectus and except for the conversion of all of the
Company's Series A and Series A-1 Preferred Shares (the "Preferred Shares")
immediately upon the Closing). All issued and outstanding shares of the
Company have been duly authorized and validly issued and are fully paid and
non-assessable; the holders of the outstanding shares of the Company have
irrevocably waived any entitlement to pre-emptive or other rights to
acquire the Common Shares in connection with the Offering; none of the
outstanding shares of the Company was issued in violation of the preemptive
or other similar rights of any securityholder of the Company. Except as
otherwise disclosed in the General Disclosure Package and the Prospectus,
there are no outstanding securities convertible into or exchangeable for,
or warrants or rights to purchase from the Company Common Shares or any
other shares of capital stock or share capital of any of the Company and
the Group Entities nor are there any obligations of the Company to allot,
issue or transfer, the Securities; the Securities are freely transferable
by the Company to or for the account of the Underwriters and (to the extent
described in the Prospectus) the initial purchasers thereof; and there are
no restrictions on subsequent transfers of the Securities under the laws of
the Cayman Islands or the United States.

(ix) Authorization of Underwriting Agreement. This Agreement has been
duly authorized, executed and delivered by the Company.

(x) Authorization of Deposit Agreement. The Deposit Agreement has been
duly authorized, executed and delivered by the Company and, assuming due
authorization, execution and delivery by the Depositary, constitutes a
valid and legally binding obligation of the Company, enforceable in
accordance with its terms, subject as to enforcement to bankruptcy,
insolvency, reorganization and other laws of general applicability relating
to or affecting creditors' rights generally and to general equity
principles.

(xi) Proper Form of Agreements. This Agreement and the Deposit
Agreement are in proper form under the laws of the Cayman Islands for the
enforcement thereof against the Company in accordance with the laws of the
Cayman Islands and to ensure the legality, validity, enforceability or
admissibility into evidence in the Cayman Islands of this Agreement and the
Deposit Agreement; it is not necessary that this Agreement, the

8


Deposit Agreement, the Prospectus or any other document be filed or
recorded with any court or other authority in the Cayman Islands or that
any Cayman Islands stamp duty or similar tax be paid on or in respect of
this Agreement, the Deposit Agreement or any other document to be furnished
hereunder or thereunder, provided each is executed outside of the Cayman
Islands.

(xii) Validity of ADRs. Upon the due issuance by the Depositary of
ADRs evidencing the ADSs against the deposit of the Common Shares in
accordance with the provisions of the Deposit Agreement, such ADRs will be
duly and validly issued under the Deposit Agreement and persons in whose
names such ADRs are registered will be entitled to the rights of registered
holders of ADRs evidencing the ADSs specified therein and in the Deposit
Agreement.

(xiii) Validity of Preferred Shares. All the outstanding Preferred
Shares have been duly authorized and validly issued and are fully paid and
non-assessable and conform to the descriptions thereof contained in the
General Disclosure Package and the Prospectus in all material respects; all
the Common Shares issuable upon the mandatory conversion of the Preferred
Share as described in the General Dislcosure Package and the Prospectus
have been duly authorized; and, immediately upon the Closing, all the
Preferred Shares will be converted into Common Shares of the Company and
all such Common Shares will be validly issued and fully paid and
non-assessable.

(xiv) Stock Options. All grants of options to acquire Common Shares
granted by the Company ("Company Stock Options") were validly issued and
properly approved by the board of directors of the Company (the "Board") in
material compliance with all applicable laws and the terms of the plans
under which such Company Stock Options were issued and were recorded on the
Company financial statements included in the Registration Statement, the
General Disclosure Package and the Prospectus in accordance with US GAAP,
and no such grants involved any "back-dating," "forward dating," "spring
loading" or similar practices with respect to the effective date of grant.

(xv) No Limitation on Vote, Transfer and Payment of Dividends. Except
as set forth in the Articles of Association, the Deposit Agreement, the
General Disclosure Package or the Prospectus and, except for applicable
securities law restrictions on the sale of securities, there are no
limitations on the rights of holders of Common Shares, ADSs or ADRs
evidencing the ADSs to hold or vote or transfer their respective
securities, and no approvals are currently required in the Cayman Islands
in order for the Company to pay dividends declared by the Company to the
holders of Common Shares, including the Depositary and, except as disclosed
in the General Disclosure Package and the Prospectus, no such dividends or
other distributions will be subject to withholding or other taxes under the
laws and regulations of the Cayman Islands and may be so paid without the
necessity of obtaining any Governmental License (as defined in Section
1(a)(xxv)) in the Cayman Islands.

(xvi) Authorization and Description of Securities. The sale of the
Securities by the Company does not violate any of the Company's internal
policies regarding the sale of shares by its affiliates. The Securities to
be purchased by the Underwriters from the

9


Company have been duly authorized for issuance and sale to the Underwriters
pursuant to this Agreement and, when issued and delivered by the Company
against payment therefor in accordance with this Agreement and, in the case
of the ADSs, the Deposit Agreement, will be validly issued, fully paid and
non-assessable and will be issued free and clear of all liens,
encumbrances, equities or claims; the Common Shares, the ADRs and the ADSs
conform to all statements relating thereto contained in the General
Disclosure Package and the Prospectus, including statements under the
captions "Description of Share Capital" and "Description of American
Depositary Shares" and such descriptions conform in all material respects
to the rights set forth in the instruments defining the same; except as
otherwise disclosed in the General Disclosure Package and the Prospectus,
no holder of the Securities is or will be subject to personal liability by
reason of being such a holder; and the issuance of the Securities is not
subject to the preemptive or other similar rights of any securityholder of
the Company.

(xvii) Absence of Defaults and Conflicts. None of the Company or the
Group Entities is in violation of its charter or by-laws or other
constituent or organizational documents or in default in the performance or
observance of any obligation, agreement, covenant or condition contained in
any contract, indenture, mortgage, deed of trust, loan or credit agreement,
note, lease or other agreement or instrument to which any of the Company
and the Group Entities is a party or by which it or any of them may be
bound, or to which any of the property or assets of any of the Company and
the Group Entities is subject (collectively, "Agreements and Instruments")
except for such defaults that would not result in a Material Adverse
Effect; and the execution, delivery and performance of each of the
Principal Agreements and the consummation of the transactions contemplated
in each of the Principal Agreements, the Registration Statement (including
the issuance and sale of the Securities and the use of the proceeds from
the sale of the Securities as described in the Prospectus under the caption
"Use of Proceeds") and compliance by the Company with its obligations under
each of the Principal Agreements have been duly authorized by all necessary
corporate action and received all necessary approvals from any governmental
or regulatory body and the necessary sanction or consent of its
shareholders and do not and will not, whether with or without the giving of
notice or passage of time or both, conflict with or constitute a breach of,
or default or Repayment Event (as defined below) under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property
or assets of any of the Company and the Group Entities pursuant to, the
Agreements and Instruments (except for such conflicts, breaches, defaults
or Repayment Events or liens, charges or encumbrances that would not result
in a Material Adverse Effect), nor will such action result in any violation
of the provisions of the charter or by-laws or other constituent or
organizational documents or business license or other organizational
document of any of the Company and the Group Entities or any applicable
treaty, law, statute, rule, regulation, judgment, order, writ or decree of
any government, government instrumentality or court, domestic or foreign,
having jurisdiction over any of the Company and the Group Entities or any
of their assets, properties or operations. As used herein, a "Repayment
Event" means any event or condition that gives the holder of any note,
debenture or other evidence of indebtedness (or any person acting on such
holder's behalf) the right to require the repurchase, redemption or
repayment of all or a portion of such indebtedness by any of the Company
and the Group Entities.

10


(xviii) Arrangements with Directors, Executive Officers and
Affiliates. Except as disclosed in the General Disclosure Package or the
Prospectus or filed as exhibits thereto, no material indebtedness (actual
or contingent) and no material contract or arrangement is outstanding
between any of the Company and the Group Entities and any director or
executive officer of the Company or any person connected with such director
or executive officer (including his/her spouse or infant children or any
company or undertaking in which he/she holds a controlling interest). There
are no relationships or transactions between any of the Company and the
Group Entities on the one hand and its or their affiliates, officers and
directors or their shareholders, customers or suppliers on the other hand
that are required to be disclosed under the 1933 Act or the 1933 Act
Regulations but are not disclosed in the Registration Statement.

(xix) Absence of Labor Dispute. No labor dispute with the employees of
any of the Company and the Group Entities exists or, to the knowledge of
the Company, is imminent, and the Company is not aware of any existing or
imminent labor disturbance by the employees of any of its or the Group
Entities' principal suppliers, manufacturers, customers or contractors,
which, in either case, would result in a Material Adverse Effect.

(xx) Absence of Proceedings. There is no action, suit, proceeding,
inquiry or investigation before or brought by any court or governmental
agency or body, domestic or foreign, now pending, or, to the knowledge of
the Company, threatened, against or affecting any of the Company and the
Group Entities, that is required to be disclosed in the General Disclosure
Package or the Prospectus (other than as disclosed therein), or that might
result in a Material Adverse Effect, or that might materially and adversely
affect the properties or assets thereof or the consummation of the
transactions contemplated in the Principal Agreements or the performance by
the Company of its obligations thereunder; the aggregate of all pending
legal or governmental proceedings to which any of the Company and the Group
Entities is a party or of which any of their respective property or assets
is the subject that are not described in the General Disclosure Package or
the Prospectus, including ordinary routine litigation incidental to the
business of any of the Company and the Group Entities, could not result in
a Material Adverse Effect.

(xxi) Possession of Intellectual Property. Each of the Company and the
Group Entities owns or possesses or otherwise has the legal right to use,
or can acquire on reasonable terms, adequate patents, patent rights,
licenses, inventions, copyrights, know-how (including trade secrets and
other unpatented and/or unpatentable proprietary or confidential
information, systems or procedures), trademarks, service marks, trade names
or other intellectual property (collectively, "Intellectual Property")
necessary to carry on the business now operated by them, and none of the
Company or the Group Entities has received any notice or is otherwise aware
of any infringement of or conflict with asserted rights of others with
respect to any Intellectual Property or of any facts or circumstances which
would render any Intellectual Property invalid or inadequate to protect the
interest of any of the Company and the Group Entities therein, and which
infringement or conflict (if the subject of any unfavorable decision,
ruling or finding) or invalidity or inadequacy, individually or in the
aggregate, would result in a Material Adverse Effect.

11


(xxii) Absence of Further Requirements for the Offering. No filing
with, or authorization, approval, consent, license, order, registration,
qualification or decree of, any court or governmental authority or agency
or any stock exchange authority is necessary or required for the
performance by the Company of its obligations under any of the Principal
Agreements in connection with the offering, issuance or sale of the
Securities under the Principal Agreements or the consummation of the
transactions contemplated hereby, except (i) such as have been already
filed, obtained or as may be required under the 1933 Act or the 1933 Act
Regulations or U.S. federal, state or local securities or blue sky laws or
stock exchange rules and regulations and (ii) such as have been obtained
under the laws and regulations of jurisdictions outside the United States
in which the Reserved Securities are offered.

(xxiii) Absence of Manipulation. Neither the Company nor any affiliate
of the Company has taken, nor will the Company or any affiliate take,
directly or indirectly, any action which is designed to or which has
constituted or which would be expected to cause or result in stabilization
or manipulation of the price of any security of the Company to facilitate
the sale or resale of the Securities.

(xxiv) Dividends. Except as otherwise disclosed in the General
Disclosure Package and the Prospectus, none of the Group Entities is
currently prohibited, directly or indirectly, from paying any dividends or
other distributions to the Company, from making any other distribution on
its equity interest, or from transferring any of its property or assets to
the Company; except as disclosed in the General Disclosure Package and the
Prospectus, all dividends and other distributions declared and payable upon
the equity interests in ATA Testing and ATA Learning to the ATA BVI may be
converted into foreign currency that may be freely transferred out of the
People's Republic of China (the "PRC").

(xxv) Free Writing Prospectuses. The Company has complied with the
requirements of Rule 433 under the 1933 Act with respect to each Issuer
Free Writing Prospectus including, without limitation, all prospectus
delivery, filing, record retention and legending requirements applicable to
any such Issuer Free Writing Prospectus. The Company has not (i)
distributed any offering material in connection with the Offering other
than the Pricing Prospectus, the Final Prospectus, and any Issuer Free
Writing Prospectus, or (ii) filed, referred to, approved, used or
authorized the use of any "free writing prospectus" as defined in Rule 405
under the 1933 Act with respect to the Offering or the Securities, except
for any Issuer Free Writing Prospectus previously approved by the
Representative and any electronic road show previously approved by the
Representative.

(xxvi) Possession of Licenses and Permits. The Company and each of the
Group Entities possess such permits, licenses, approvals, consents and
other authorizations (collectively, "Governmental Licenses") issued by, and
has made all declarations and filings with, the appropriate national, local
or other regulatory agencies or bodies required for the authorization,
execution and delivery by the Company of any of the Principal Agreements or
necessary to conduct the business now operated by them, with such
exceptions as would not have a Material Adverse Effect; the Company and the
Group

12


Entities are in compliance with the terms and conditions of all such
Governmental Licenses, except where the failure to so comply would not,
individually or in the aggregate, have a Material Adverse Effect; all of
the Governmental Licenses are valid and in full force and effect, except
where the invalidity or failure to be in full force and effect would not,
individually or in the aggregate, have a Material Adverse Effect; none of
the Governmental Licenses contains any materially burdensome restrictions
or conditions not described in the General Disclosure Package and the
Prospectus; and neither the Company nor any Group Entity has received any
notice of proceedings relating to the revocation or modification of any
such Governmental Licenses which, individually or in the aggregate, if the
subject of an unfavorable decision, ruling or finding, would result in a
Material Adverse Effect or has any reason to believe that any such
Governmental License will be revoked, modified or suspended.

(xxvii) Title to Property. The Company and the Group Entities have
good and marketable title to all real property owned by the Company and the
Group Entities and good title to all other properties owned by them, in
each case, free and clear of all mortgages, pledges, liens, security
interests, claims, restrictions or encumbrances of any kind except such as
(a) are described in the General Disclosure Package and the Prospectus or
(b) do not, individually or in the aggregate, materially affect the value
of such property and do not interfere with the use made and proposed to be
made of such property by the Company or the Group Entities; and all of the
leases and subleases material to the business of the Company and the Group
Entities, individually or in the aggregate, and under which the Company or
the Group Entities hold properties described in the General Disclosure
Package and the Prospectus, are in full force and effect, and neither the
Company nor any Group Entity has any notice of any material claim of any
sort that has been asserted by anyone adverse to the rights of the Company
or the Group Entities under any of the leases or subleases mentioned above,
or affecting or questioning the rights of the Company or the Group Entities
to the continued possession of the leased or subleased premises under any
such lease or sublease; and no party to any of the leases or subleases is
in violation or breach of any PRC national, provincial, municipal or other
local law, regulation, statute, rule or order, which violation or breach
could invalidate, impair or result in any fine, penalty or government
sanction with regard to any lease or sublease, except as described in the
General Disclosure Package and the Prospectus.

(xxviii) Investment Company Act. The Company is not, and upon the
issuance and sale of the Securities as herein contemplated and the
application of the net proceeds therefrom as described in the General
Disclosure Package and the Prospectus will not be, an "investment company"
as such term is defined in the Investment Company Act of 1940, as amended
(the "1940 Act") immediately after the Offering.

(xxix) Environmental Laws. Except as described in the General
Disclosure Package and the Prospectus and except as would not, singly or in
the aggregate, result in a Material Adverse Effect, (i) none of the Company
or the Group Entities is in violation of any national, local or foreign
statute, law, rule, regulation, ordinance, code, policy or rule of common
law or any judicial or administrative interpretation thereof, including any
judicial or administrative order, consent, decree or judgment, relating to
pollution or protection of human health, the environment (including,
without limitation, ambient air,

13


surface water, groundwater, land surface or subsurface strata) or wildlife,
including, without limitation, laws and regulations relating to the release
or threatened release of chemicals, pollutants, contaminants, wastes, toxic
substances, hazardous substances, petroleum or petroleum products,
asbestos-containing materials or mold (collectively, "Hazardous Materials")
or to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials (collectively,
"Environmental Laws"), (ii) each of the Company and the Group Entities has
all permits, authorizations and approvals required under any applicable
Environmental Laws and is each in compliance with their requirements, (iii)
there are no pending or threatened administrative, regulatory or judicial
actions, suits, demands, demand letters, claims, liens, notices of
noncompliance or violation, investigation or proceedings relating to any
Environmental Law against any of the Company and the Group Entities and
(iv) there are no events or circumstances that might reasonably be expected
to form the basis of an order for clean-up or remediation, or an action,
suit or proceeding by any private party or governmental body or agency,
against or affecting any of the Company and the Group Entities relating to
Hazardous Materials or any Environmental Laws.

(xxx) Passive Foreign Investment Company Status. Based on the
projected composition of the Company's income and valuation of its assets,
including goodwill, the Company does not expect to become a passive foreign
investment company, as defined in Section 1296(a) of the United States
Internal Revenue Code of 1986, as amended (the "Code"), in 2008, and does
not expect to become a passive foreign investment company in the future.

(xxxi) No Finder's Fee. Except as described in the General Disclosure
Package and the Prospectus, there are no contracts, agreements, or
understandings between the Company and any person that would give rise to a
valid claim against the Company or any Underwriter for a brokerage
commission, finder's fee or other like payment in connection with the
transactions contemplated by this Agreement and the Deposit Agreement or,
to the Company's knowledge, any arrangements, agreements, understandings,
payments or issuance with respect to the Company or any of its officers,
directors, shareholders, partners, employees, any of the Group Entities or
affiliates that may affect the Underwriters' compensation as determined by
FINRA.

(xxxii) No Unapproved Marketing Documents. The Company has not
distributed and, prior to the later to occur of any Date of Delivery and
completion of the distribution of the Securities, will not distribute any
offering material in connection with the offering and sale of the
Securities other than any preliminary prosepctus, the General Disclosure
Package, the Prospectus and any Issuer Free Writing Prospectus to which the
Representative has consented in accordance with this Agreement.

(xxxiii) Registration Rights. Except as described in the General
Disclosure Package and the Prospectus, there are no persons with
registration rights or other similar rights to have any securities
registered pursuant to the Registration Statement or otherwise registered
by the Company under the 1933 Act.

14


(xxxiv) Employee Benefits. Except as set forth in the General
Disclosure Package and the Prospectus, the Company has no obligation to
provide retirement, death or disability benefits to any of the present or
past employees of the Company or any Group Entity, or to any other person;
each of the Company and the Group Entities are in compliance with all
applicable laws relating to employee benefits.

(xxxv) Pro Forma Financial Information. There are no pro forma or as
adjusted financial statements which are required to be included in the
Registration Statement, the General Disclosure Package and the Prospectus
in accordance with Regulation S-X that have not been included as so
required.

(xxxvi) Compliance of Internal Controls with the 1934 Act. The Company
maintains a system of internal control over financial reporting (as such
term is defined in Rule 13a-15(f) under the 1934 Act) that complies with
the requirements of the 1934 Act that are applicable to the Company and has
been designed by the Company's principal executive officer and principal
financial officer, or under their supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance
with US GAAP; except as disclosed in the General Disclosure Package and the
Prospectus, the Company is not aware of (i) any significant deficiency or
material weakness in the design or operation of internal control over
financial reporting which is reasonably likely to adversely affect the
company's ability to record, process, summarize or report financial
information, or (ii) any fraud, whether or not material, that involves
management or other employees who have a significant role in the Company's
internal control over financial reporting; since the date of the latest
audited financial statements included in the General Disclosure Package and
the Prospectus, there has been no change in the Company's internal control
over financial reporting that has materially affected, or is reasonably
likely to materially affect, the Company's internal control over financial
reporting other than as disclosed in the General Disclosure Package and the
Prospectus.

(xxxvii) Compliance of Disclosure Controls and Procedures. The Company
maintains disclosure controls and procedures (as such term is defined in
Rule 13a-15(e) under the 1934 Act) that comply with the requirements of the
1934 Act that are applicable to the Company and have been designed by the
Company's principal executive officer and principal financial officer, or
under their supervision, to ensure that material information relating to
each of the Company and the Group Entities is made known to the Company's
Principal Executive Officer and Principal Financial Officer by others
within those entities; such disclosure controls and procedures (i) provide
for the periodic evaluation of the effectiveness of such disclosure
controls and procedures at the end of the periods in which the periodic
reports are required to be prepared and (ii) except as disclosed in the
General Disclosure Package and the Prospectus, are effective in all
material respects to perform the functions for which they were established.
Except as set forth in the General Disclosure Package and the Prospectus,
the Company has not publicly disclosed or reported to the audit committee
or the Board, and within the next 135 days the Company does not reasonably
expect to publicly disclose or report to the audit committee or the Board,
a significant deficiency, material weakness, change in such internal
controls or fraud involving management or other employees who have a

15


significant role in such internal controls (each, an "Internal Control
Event"), any violation of, or failure to comply with, any securities laws,
or any matter which, if determined adversely, would have a Material Adverse
Effect.

(xxxviii) Accounting Controls. Each of the Company and the Group
Entities maintain a system of internal accounting controls sufficient to
provide reasonable assurances that (i) transactions are executed in
accordance with management's general or specific authorization; (ii)
transactions are recorded as necessary to permit preparation of financial
statements in conformity with US GAAP and to maintain accountability for
assets; (iii access to assets is permitted only in accordance with
management's general or specific authorization; (iv) the recorded
accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences; and (v) financial reports are prepared on a timely basis based
on the transactions recorded pursuant to clause (ii) above under US GAAP.
These reports provide the basis for the preparation of the Company's
consolidated financial statements under US GAAP and have been maintained in
compliance with applicable laws. Except as described in the General
Disclosure Package and the Prospectus, since the end of the Company's most
recent audited fiscal year, there has been (x) no material weakness in the
Company's internal control over financial reporting (whether or not
remediated) and (y) no change in the Company's internal control over
financial reporting that has materially affected, or is reasonably likely
to materially affect, the Company's internal control over financial
reporting.

(xxxix) Absence of Accounting Issues. The Board has confirmed to the
Chief Executive Officer, Chief Financial Officer or General Counsel of the
Company that, except as set forth in the General Disclosure Package and the
Prospectus, the Board is not reviewing or investigating, and neither the
Company's independent auditors nor its internal auditors have recommended
that the Board review or investigate, (i) adding to, deleting, changing the
application of, or changing the Company's disclosure with respect to, any
of the Company's material accounting policies; (ii) any matter which could
result in a restatement of the Company's financial statements for any
annual or interim period during the current or prior three fiscal years; or
(iii) any Internal Control Event.

(xl) Compliance with the Sarbanes-Oxley Act. The Company has taken all
necessary actions to ensure that, upon the effectiveness of the
Registration Statement, it will be in compliance with all provisions of the
Sarbanes-Oxley Act of 2002 and all rules and regulations promulgated
thereunder or implementing the provisions thereof (the "Sarbanes-Oxley
Act") which the Company is required to comply with as of the effectiveness
of the Registration Statement, and is actively taking steps to ensure that
it will be in compliance with other provisions of the Sarbanes-Oxley Act
which will become applicable to the Company at all times after the
effectiveness of the Registration Statement.

(xli) Payment of Taxes. All applicable income tax returns of each of
the Company and the Group Entities required by law to be filed have been
filed and all taxes shown by such returns or otherwise assessed which are
due and payable have been paid, except assessments against which appeals
have been or will be promptly taken and as to

16


which adequate reserves have been provided. All tax returns of the Company
through the tax year ended December 31, 2007 required by law to be filed
have been settled and no assessment in connection therewith has been made
against the Company. Each of the Company and the Group Entities has filed
all other tax returns that are required to have been filed by them pursuant
to applicable national, local or other law except insofar as the failure to
file such returns would not result in a Material Adverse Effect, and has
paid all taxes due pursuant to such returns or pursuant to any assessment
received by any of the Company and the Group Entities, except for such
taxes, if any, as are being contested in good faith and as to which
adequate reserves have been provided. The charges, accruals and reserves on
the books of the Company in respect of any income and corporation tax
liability for any years not finally determined are adequate to meet any
assessments or re-assessments for additional income tax for any years not
finally determined, except to the extent of any inadequacy that would not
result in a Material Adverse Effect.

(xlii) Insurance. Each of the Company and the Group Entities carries
or is entitled to the benefits of insurance, with financially sound and
reputable insurers, in such amounts and covering such risks as is generally
maintained by companies of established repute engaged in the same or
similar business in the PRC, and all such insurance is in full force and
effect. The Company has no reason to believe that it or any Group Entity
will not be able (i) to renew its existing insurance coverage as and when
such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as
now conducted and at a cost that would not result in a Material Adverse
Change. Neither the Company nor any Group Entity has been denied any
insurance coverage which it has sought or for which it has applied. So far
as the Company is aware (x) there are no circumstances which would
reasonably be expected to render such insurance void or voidable and there
is no material insurance claim made by or against any of the Company and
the Group Entities, pending, threatened or outstanding and (y) no facts or
circumstances exist which would reasonably be expected to give rise to any
such claim and all due premiums in respect thereof have been paid.

(xliii) Statistical and Market-Related Data. Any statistical and
market-related data included in the General Disclosure Package and the
Prospectus are based on or derived from sources that the Company believes
to be reliable and accurate, and the Company has obtained the written
consent to the use of such data from such sources.

(xliv) MD&A Description. The section entitled "Management's Discussion
and Analysis of Financial Condition and Results of Operations" in the
General Disclosure Package and the Prospectus accurately and fully
describes (i) accounting policies that the Company believes are the most
important in the portrayal of the Company's financial condition and results
of operations and that require management's most difficult, subjective or
complex judgments ("critical accounting policies"), (ii) judgments and
uncertainties affecting the application of critical accounting policies,
and (iii) the likelihood that materially different amounts would be
reported under different conditions or using different assumptions and an
explanation thereof.

17


(xlv) Management Review. The Company's management have reviewed and
agreed with the selection, application and disclosure of critical
accounting policies and have consulted with its legal advisers and
independent accountants with regards to such disclosure.

(xlvi) Liquidity and Capital Resources. The section entitled
"Management's Discussion and Analysis of Financial Condition and Results of
Operations--Liquidity and Capital Resources" in the General Disclosure
Package and the Prospectus accurately and fully describes: (i) all material
trends, demands, commitments, events, uncertainties and risks, and the
potential effects thereof, that the Company believes would materially
affect liquidity and are reasonably likely to occur, and (ii) none of the
Company or the Group Entities is engaged in any transactions with, or have
any obligations to, its unconsolidated entities (if any) that are
contractually limited to narrow activities that facilitate the transfer of
or access to assets by any of the Company and the Group Entities,
including, without limitation, structured finance entities and special
purpose entities, or otherwise engage in, or have any obligations under,
any off-balance sheet transactions or arrangements. As used herein, the
phrase "reasonably likely" refers to a disclosure threshold lower than
"more likely than not."

(xlvii) Stamp Duty; Transfer Tax. Except as disclosed in the General
Disclosure Package and the Prospectus, under the laws and regulations of
the PRC and the Cayman Islands, no transaction, stamp, capital or other
issuance, registration or transfer taxes or duties are payable in the PRC
or the Cayman Islands by or on behalf of the Underwriters to any PRC or
Cayman Islands taxing authority in connection with (i) the issuance, sale
and delivery by the Company to or for the account of the Underwriters of
the Securities, (ii) the initial sale and delivery by the Underwriters of
the Securities to purchasers thereof, (iii) the holding or transfer of the
Securities outside the PRC or the Cayman Islands, (iv) the deposit of the
Common Shares with the Custodian and the issuance and delivery of the ADRs,
or (v) other than nominal stamp duty if this Agreement is executed in the
Cayman Islands, the execution and delivery of any agreement in connection
with the Offering.

(xlviii) Accuracy of Information. There are no legal or governmental
proceedings, statutes, contracts or documents that are required under the
1933 Act or the 1933 Act Regulations to be described in the General
Disclosure Package or the Prospectus which have not been so described.
There are no contracts or documents that are required to be described in
the Registration Statement, the General Disclosure Package or the
Prospectus or to be filed as exhibits thereto that have not been so
described and filed as required. The description in the General Disclosure
Package and the Prospectus of statutes, legal and governmental proceedings
and contracts and other documents is accurate and presents the information
required to be shown in all material respects. The Prospectus will contain,
when issued, all information and particulars required to comply with all
statutory and other provisions (including, without limitation, the relevant
laws and regulations of the Cayman Islands and the PRC) so far as
applicable in the Prospectus, which is or might reasonably be considered to
be material for disclosure to a potential subscriber, investor, underwriter
or sub-underwriter of the Securities or for the purpose of making an
informed assessment of the assets and

18

liabilities, financial position, and profits and losses of each of the
Company and the Group Entities including, but without prejudice to the
generality of the foregoing, any special trade factors or risks known to
any of the Company and the Group Entities or any of their directors and/or
executive officers and which would reasonably be expected to have a
Material Adverse Effect. All material information which ought to have been
supplied or disclosed by the Company and its directors and/or executive
officers to the Underwriters, the Representative, KPMG or the legal or
other professional advisers to the Underwriters or the Company for the
purposes of or in the course of preparation of the General Disclosure
Package or the Prospectus has been supplied or disclosed by the Company and
its directors and executive officers and nothing has occurred since the
date the same was supplied or disclosed which requires the same to be
amended or updated in any material respect.

(xlix) Choice of Law; Consent to Jurisdiction; Appointment of Agent
for Service of Process. The choice of the laws of the State of New York as
the governing law of this Agreement is a valid choice of law under the laws
of the PRC and the Cayman Islands and will be honored by courts in the PRC
and the Cayman Islands. The Company has the power to submit, and pursuant
to Section 14 of this Agreement, has legally, validly, effectively and
irrevocably submitted, to the personal jurisdiction of each United States
federal court and New York state court located in the Borough of Manhattan,
in The City of New York, New York, United States of America (each, a "New
York Court"), and the Company has the power to designate, appoint and
empower, and pursuant to Section 14 of this Agreement, has legally,
validly, effectively and irrevocably designated, appointed and empowered,
the Authorized Agent (as defined in Section 14 hereof) for service of
process in any action arising out of or relating to this Agreement or the
Securities in any New York Court, and service of process effected on such
Authorized Agent will be effective to confer valid personal jurisdiction
over the Company as provided in Section 14 hereof.

(l) Waiver of Immunity. None of the Company, the Group Entities or any
of the Company's or any of the Group Entity's properties, assets or
revenues has any right of immunity under PRC, Cayman Islands or New York
law, from any legal action, suit or proceeding, from the giving of any
relief in any such legal action, suit or proceeding, from set-off or
counterclaim, from the jurisdiction of any PRC, Cayman Islands, New York or
U.S. federal court, from service of process, attachment upon or prior to
judgment, or attachment in aid of execution of judgment, or from execution
of a judgment, or other legal process or proceeding for the giving of any
relief or for the enforcement of a judgment, in any such court, with
respect to its obligations, liabilities or any other matter under or
arising out of or in connection with this Agreement; and, to the extent
that each of the Company and the Group Entities or any of the Company's or
any Group Entity's properties, assets or revenues may have or may hereafter
become entitled to any such right of immunity in any such court in which
proceedings may at any time be commenced, each of the Company and the Group
Entities waives or will waive such right to the extent permitted by law and
has consented to such relief and enforcement as provided in Section 13 of
this Agreement.

19


(li) Enforceability of New York Judgment. The courts of the Cayman
Islands would recognize as a valid judgment, a final and conclusive
judgment in personam obtained in the New York Courts against the Company
based upon this Agreement under which a sum of money is payable (other than
a sum of money payable in respect of multiple damages, taxes or other
charges of a like nature or in respect of a fine or other penalty) and
would give a judgment based thereon provided that (i) such courts had
proper jurisdiction over the parties subject to such judgment, (ii) such
courts did not contravene the rules of natural justice of the Cayman
Islands, (iii) such judgment was not obtained by fraud, (iv) the
enforcement of the judgment would not be contrary to the public policy of
the Cayman Islands, (v) no new admissible evidence relevant to the action
is submitted prior to the rendering of the judgment by the courts of the
Cayman Islands, and (vi) there is due compliance with the correct
procedures under the laws of the Cayman Islands.

(lii) Listing. The Securities have been authorized for quotation,
subject to official notice of issuance, on the Nasdaq Global Market
("NASDAQ"), under the symbol "ATAI".

(liii) Contingent Obligations. Except as disclosed in the General
Disclosure Package and the Prospectus, there are no outstanding guarantees
or other contingent obligations of any of the Company and the Group
Entities that could reasonably be expected to have a Material Adverse
Effect.

(liv) Integration of Other Offerings. Neither the Company nor any of
its affiliates (within the meaning of Rule 144 under the 1933 Act) has,
prior to the date hereof, made any offer or sale of any securities which
could be "integrated" (within the meaning of the 1933 Act and the 1933 Act
Regulations) with the offer and sale of the Securities pursuant to the
Registration Statement. Except as disclosed in the Registration Statement,
the General Disclosure Package and the Prospectus, neither the Company nor
any of its affiliates has sold or issued (i) any Securities or other
security of the Company, (ii) any security convertible into, or exercisable
or exchangeable for, Common Shares or any other security of the Company,
(iii) any equity interest or other security of any Group Entity or (iv) any
security convertible into, or exercisable or exchangeable for, such equity
interest or any other security of any Group Entity during the six-month
period preceding the date of the Prospectus, including but not limited to
any sales pursuant to Rule 144A, Regulation D or Regulation S under the
1933 Act.

(lv) Foreign Corrupt Practices. Neither the Company nor, to the
knowledge of the Company, any director, officer, agent, employee, affiliate
or other person acting on behalf of the Company or any Group Entity is
aware of or has taken any action, directly or indirectly, that would result
in a violation by such persons of the Foreign Corrupt Practices Act of
1977, as amended, and the rules and regulations thereunder (the "FCPA"),
including, without limitation, making use of the mails or any means or
instrumentality of interstate commerce corruptly in furtherance of an
offer, payment, promise to pay or authorization of the payment of any
money, or other property, gift, promise to give, or authorization of the
giving of anything of value to any "foreign official" (as such term is
defined in the FCPA) or any foreign political party or official thereof or
any candidate for

20


foreign political office, in contravention of the FCPA and the Company and,
to the knowledge of the Company, its affiliates have conducted their
businesses in compliance with the FCPA and have instituted and maintain
policies and procedures designed to ensure, and which are reasonably
expected to continue to ensure, continued compliance therewith.

(lvi) OFAC Compliance. None of the Company and the Group Entities,
nor, to the Company's knowledge, any of their respective officers,
directors, managers, agents, employees or affiliates thereof is currently
subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department ("OFAC"); and neither the Company
nor any Group Entity will, directly or indirectly, use the proceeds of this
Offering, or lend, contribute or otherwise make available such proceeds to
any subsidiary, joint venture partner or other person or entity, for the
purpose of financing the activities of any person currently subject to any
U.S. sanctions administered by OFAC.

(lvii) Compliance with Money Laundering Laws. The operations of each
of the Company and the Group Entities are and have been conducted at all
times in compliance with financial record-keeping and reporting
requirements of all applicable jurisdictions and the money laundering
statutes of all applicable jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines
issued, administered or enforced by any governmental agency (collectively,
the "Money Laundering Laws"), and no action, suit or proceeding by or
before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Group Entity with respect to the
Money Laundering Laws is pending or, to the best knowledge of the Company,
threatened.

(lviii) Reserved Securities Sales. The Company has not offered, or
caused the Representative to offer, Reserved Securities to any person with
the specific intent to unlawfully influence (i) a customer or supplier of
the Company or any of its affiliates to alter the customer's or supplier's
level or type of business with any such entity or (ii) a trade journalist
or publication to write or publish favorable information about the Company
or any of its affiliates, or their respective businesses or products.

(lix) SAFE Compliance. Except as otherwise described in the General
Disclosure Package and the Prospectus, the Company has taken all reasonable
steps to comply with, and to ensure compliance by all of the Company's
shareholders who are PRC residents or PRC citizens with any applicable
rules and regulations of the State Administration of Foreign Exchange (the
"SAFE Rules and Regulations"), including without limitation, taking
reasonable steps to require each shareholder that is, or is directly or
indirectly owned or controlled by, a PRC resident or PRC citizen to
complete any registration and other procedures required under applicable
SAFE Rules and Regulations.

(lx) No Trading. None of the Company or the Group Entities is engaged
in any trading activities involving commodity contracts or other trading
contracts which are not currently traded on a securities or commodities
exchange and for which the market value cannot be determined.

21


(lxi) No Association with FINRA. Except as disclosed in the
Registration Statement, neither the Company nor any of his, her or its
affiliates directly, or indirectly through one or more intermediaries,
controls, or is controlled by, or is under common control with, or has any
other association with (within the meaning of Article I, Section 1(dd) of
the By-laws of FINRA), any member firm of FINRA.

(lxii) M&A Rules. The Company is aware of and has been advised as to,
the content of the Rules on Mergers and Acquisitions of Domestic
Enterprises by Foreign Investors jointly promulgated by the Ministry of
Commerce, the State Assets Supervision and Administration Commission, the
State Tax Administration, the State Administration of Industry and
Commerce, the China Securities Regulatory Commission ("CSRC") and the State
Administration of Foreign Exchange of the PRC on August 8, 2006 (the "M&A
Rules"), in particular the relevant provisions thereof which purport to
require offshore special purpose vehicles ("SPVs") formed for listing
purposes and controlled directly or indirectly by PRC companies or
individuals, to obtain the approval of the CSRC prior to the listing and
trading of their securities on stock exchange located outside of the PRC;
the Company has received legal advice specifically with respect to the M&A
Rules from its PRC counsel and the Company understands such legal advice;
and the Company has fully communicated such legal advice from its PRC
counsel to each of its directors that signed the Registration Statement and
each such director has confirmed that he or she understands such legal
advice.

(lxiii) M&A Clarifications. The issuance and sale of the Securities,
the listing and trading of the ADSs on the NASDAQ or the consummation of
the transactions contemplated by this Agreement, the Deposit Agreement and
the Power of Attorney is not and will not be, as of the date hereof or at
each Date of Delivery, adversely affected by the M&A Rules or any official
clarifications, guidance, interpretations or implementation rules in
connection with or related to the M&A Rules, including the guidance and
notices issued by the CSRC on September 8 and September 21, 2006
(collectively, the "M&A Rules and Related Clarifications").

(lxiv) Non-applicability of M&A Rules. As of the date hereof, the M&A
Rules did not and do not require the Company to obtain the approval of the
CSRC prior to the issuance and sale of the Securities, the listing and
trading of the ADSs on the NASDAQ, or the consummation of the transactions
contemplated by this Agreement, the Deposit Agreement and the Power of
Attorney.

(lxv) Disclosure of M&A Rules. The statements set forth in the General
Disclosure Package under the captions "Risk Factors--Risks Related to
Regulation of Our Business - If the China Securities Regulatory Commission,
or CSRC, or another PRC regulatory agency determines that CSRC approval is
required in connection with this offering, this offering may be delayed or
cancelled, or we may become subject to penalties" are fair and accurate
summaries of the matters described therein, and nothing has been omitted
from such summaries which would make the same misleading in any material
respect.

22


(lxvi) Directors and Senior Management. Other than the persons
described in the General Disclosure Package and the Prospectus under the
caption "Directors and Executive Officers" in the section entitled
"Management", there are no other persons having authority and
responsibility for planning, directing and controlling the activities of
the Company or considered to be key management personnel of the Company or
otherwise required to be described in the General Disclosure Package or the
Prospectus pursuant to Item 6 of Form 20-F.

(b) Officer's Certificates. Any certificate signed by any officer of the
Company or of any Group Entity delivered to the Representative or to counsel for
the Underwriters shall be deemed a representation and warranty by the Company to
the Underwriters as to the matters covered thereby.

SECTION 2. Sale and Delivery to the Underwriters; Closing.

(a) Initial Securities. On the basis of the representations and warranties
herein contained and subject to the terms and conditions herein set forth, the
Company agrees to sell to each Underwriter, severally and not jointly, and each
Underwriter, severally and not jointly, agrees to purchase from the Company, at
the price per ADS set forth in Schedule B, that the number of Initial Securities
set forth in Schedule A opposite the name of such Underwriter, plus any
additional number of Initial Securities that such Underwriter may become
obligated to purchase pursuant to the provisions of Section 10 hereof, bears to
the total number of Initial Securities, subject, in each case, to such
adjustments among the Underwriters as the Representative in its sole discretion
shall make to eliminate any sales or purchases of fractional securities.

(b) Option Securities. In addition, on the basis of the representations and
warranties herein contained and subject to the terms and conditions herein set
forth, the Company hereby grants an option to the Underwriters, severally and
not jointly, to purchase up to an additional [-] ADSs at the same price per ADS
set forth in Schedule B less an amount per Common Share represented by such ADSs
equal to any dividends or distributions declared by the Company and payable on
the Initial Securities but not payable on the Option Securities. The option
hereby granted will expire 30 days after the date of the Prospectus and may be
exercised in whole or in part from time to time only for the purpose of covering
over-allotments by written notice from the Representative to the Company setting
forth the aggregate number of Option Securities to be purchased and the date on
which such Option Securities are to be delivered, as determined by the
Representative but in no event earlier than the Closing Time or, unless the
Representative and the Company otherwise agree in writing, not earlier than two
or later than ten business days after the date of such notice. If the option is
exercised as to all or any portion of the Option Securities, each of the
Underwriters, acting severally and not jointly, will purchase that proportion of
the total number of Option Securities then being purchased that the number of
Initial Securities set forth in Schedule A opposite the name of such Underwriter
bears to the total number of Initial Securities, subject in each case to such
adjustments among the Underwriters as the Representative in its sole discretion
shall make to eliminate any sales or purchases of fractional shares.

(c) Denominations; Registration; Delivery of ADRs. ADRs evidencing the
Securities purchased by the Underwriters hereunder shall be delivered by the
Company to the

23

Representative through the facilities of DTC, for the respective accounts of
the Underwriters, against payment for the Securities by or on behalf of such
Underwriters to the Company of the purchase price therefor by wire transfer
through the Federal Wire System in New York in US dollars in immediately
available funds to an account designated by the Company.

(d) Time and Date of Deliveries and Payments. The time and date of delivery
of, and payment for, the Initial Securities shall be 9:30 a.m., New York City
time on [-], 2008 (unless postponed in accordance with the provisions of Section
10), or such other time not later than ten business days after such date as the
Representative and the Company may agree upon in writing (such time and date of
payment and delivery being herein called the "Closing Time"). The time and date
of delivery and payment with respect to the Option Securities shall be 9:30
a.m., New York City time on the date specified by the Representative in a
written notice given by the Representative of an election by the Underwriters to
purchase such Option Securities, or such other time and date as the
Representative and the Company may agree upon in writing. Any such time and date
for delivery of and payment for the Option Securities, if not the Closing Time,
is herein called a "Date of Delivery."

The documents to be delivered at the Closing Time by or on behalf of the
parties hereto pursuant to Section 5 hereof, including any additional documents
reasonably requested by the Underwriters pursuant to Section 5(o) hereof, will
be delivered at the offices of Simpson Thacher & Bartlett LLP, 35th Floor, ICBC
Tower, 3 Garden Road, Central, Hong Kong at 8:00 a.m., Hong Kong time, on the
day of the Closing Time.


SECTION 3. Covenants of the Company. The Company covenants with each
Underwriter as follows:

(a) Compliance with Securities Regulations and Commission Requests. The
Company, subject to Section 3(b), will comply with the requirements of Rule 430A
and will notify the Representative immediately, and confirm the notice in
writing, (i) when any post-effective amendment to the Registration Statement, to
the ADR Registration Statement or to the Form 8-A Registration Statement shall
become effective, or any supplement to the Prospectus or any amended Prospectus
shall have been filed, (ii) of the receipt of any comments from the Commission,
(iii) of any request by the Commission for any amendment to the Registration
Statement, to the ADR Registration Statement or to the Form 8-A Registration
Statement or any amendment or supplement to the Prospectus or for additional
information, (iv) of the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement, the ADR Registration Statement
or the Form 8-A Registration Statement or of any order preventing or suspending
the use of any preliminary prospectus, or of the suspension of the qualification
of the Securities for offering or sale in any jurisdiction, or of the initiation
or threatening of any proceedings for any of such purposes or of any examination
pursuant to Section 8(e) of the 1933 Act concerning the Registration Statement
and (v) if the Company becomes the subject of a proceeding under Section 8A of
the 1933 Act in connection with the Offering. The Company will promptly effect
the filings necessary pursuant to Rule 424(b) and will take such steps as it
deems necessary to ascertain promptly whether the form of prospectus transmitted
for filing under Rule 424(b) was received for filing by the Commission and, in
the event that it was not, it will promptly file such prospectus. The Company
will use its best efforts to prevent the issuance

24


of any stop order and, if any stop order is issued, to obtain the lifting
thereof at the earliest possible moment.

(b) Filing of Amendments. The Company will give the Representative notice
of its intention to file or prepare any amendment to the Registration Statement
(including any filing under Rule 462(b)), to the ADR Registration Statement or
the Form 8-A Registration Statement or any amendment, supplement or revision to
either the prospectus included in the Registration Statement at the time it
became effective or to the Prospectus, and will furnish the Representative with
copies of any such documents a reasonable amount of time prior to such proposed
filing or use, as the case may be, and will not file or use any such document to
which the Representative or counsel for the Underwriters shall object. The
Company has given and will give the Representative notice of any filings made
pursuant to the 1934 Act or 1934 Act Regulations within 48 hours prior to the
Applicable Time; the Company will give the Representative notice of its
intention to make any such filing from the Applicable Time to the Closing Time
and will furnish the Representative with copies of any such documents a
reasonable amount of time prior to such proposed filing, as the case may be, and
will not file or use any such document to which the Representative or counsel
for the Underwriters shall object.

(c) Delivery of Registration Statements. The Company has furnished or will
deliver to the Representative and counsel for the Underwriters, without charge,
signed copies of the Registration Statement, the ADR Registration Statement and
the Form 8-A Registration Statement as originally filed and of each amendment
thereto (including exhibits filed therewith or incorporated by reference
therein) and signed copies of all consents and certificates of experts, and will
also deliver to the Representative, without charge, a conformed copy of the
Registration Statement, the ADR Registration Statement and the Form 8-A
Registration Statement as originally filed and of each amendment thereto
(without exhibits) for each of the Underwriters. The copies of the Registration
Statement and each amendment thereto furnished to the Underwriters will be
identical to the electronically transmitted copies thereof filed with the
Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

(d) Delivery of Prospectus. The Company has delivered to each Underwriter,
without charge, as many copies of each preliminary prospectus as each
Underwriter reasonably requested, and the Company hereby consents to the use of
such copies for purposes permitted by the 1933 Act. The Company will furnish to
each Underwriter, without charge, during the period when the Prospectus is
required to be delivered under the 1933 Act or the 1934 Act, such number of
copies of the Prospectus (as amended or supplemented) as each Underwriter may
reasonably request. The Prospectus and any amendments or supplements thereto
furnished to the Underwriters will be identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except
to the extent permitted by Regulation S-T.

(e) Continued Compliance with Securities Laws. The Company will comply with
the 1933 Act and the 1933 Act Regulations, the 1934 Act and the 1934 Act
Regulations, the rules and regulations of FINRA and the NASDAQ so as to permit
the completion of the distribution of the Securities as contemplated in the
Principal Agreements and in the Prospectus. If at any time when a prospectus is
required by the 1933 Act to be delivered in connection with sales of the
Securities, any event shall occur or condition shall exist as a result of which
it is necessary, in the opinion of counsel for the Underwriters or for the
Company, to amend the Registration

25


Statement, the ADR Registration Statement or the Form 8-A Registration Statement
or amend or supplement the Prospectus in order that the Prospectus will not
include any untrue statements of a material fact or omit to state a material
fact necessary in order to make the statements therein not misleading in the
light of the circumstances existing at the time it is delivered to a purchaser,
or if it shall be necessary, in the opinion of such counsel, at any such time to
amend the Registration Statement, the ADR Registration Statement or the Form 8-A
Registration Statement or amend or supplement the Prospectus in order to comply
with the requirements of the 1933 Act or the 1933 Act Regulations, or the 1934
Act or the 1934 Act Regulations, the Company will promptly prepare and file with
the Commission, subject to Section 3(b), such amendment or supplement as may be
necessary to correct such statement or omission or to make the Registration
Statement, the ADR Registration Statement, the Form 8-A Registration Statement
or the Prospectus comply with such requirements, and the Company will furnish to
the Underwriters such number of copies of such amendment or supplement as the
Underwriters may reasonably request. If at any time following issuance of an
Issuer Free Writing Prospectus there occurred or occurs an event or development
as a result of which such Issuer Free Writing Prospectus conflicted or would
conflict with the information contained in the Registration Statement relating
to the Securities or included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances, prevailing at
that subsequent time, not misleading, the Company will promptly notify the
Representative and will promptly amend or supplement, at its own expense, such
Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue
statement or omission.

(f) Blue Sky Qualifications. The Company will use its best efforts, in
cooperation with the Underwriters, to qualify the Securities for offering and
sale under the applicable securities laws of such states and other jurisdictions
(within or outside the United States) as the Representative may designate and to
maintain such qualifications in effect for as long as may be necessary to
complete the distribution of the Securities, which period shall in no event
extend for more than one year from the later of the effective date of the
Registration Statement and any Rule 462(b) Registration Statement; provided,
however, that the Company shall not be obligated to file any general consent to
service of process or to qualify as a foreign corporation or as a dealer in
securities in any jurisdiction in which it is not so qualified or to subject
itself to taxation in respect of doing business in any jurisdiction in which it
is not otherwise so subject. In each jurisdiction in which the Securities have
been so qualified, the Company will file such statements and reports as may be
required by the laws of such jurisdiction to continue such qualification in
effect for as long as may be necessary to complete the distribution of the
Securities, which period shall in no event extend for more than one year from
the effective date of the Registration Statement and any Rule 462(b)
Registration Statement.

(g) Rule 158. The Company will timely file such reports pursuant to the
1934 Act as are necessary in order to make generally available to its
securityholders as soon as practicable an earnings statement for the purposes
of, and to provide to the Underwriters the benefits contemplated by, the last
paragraph of Section 11(a) of the 1933 Act.

(h) Use of Proceeds. The Company will use the net proceeds received by it
from the sale of the Securities in the manner specified in the Prospectus under
"Use of Proceeds."

26


(i) Compliance with Rule 463. The Company will file with the Commission
such reports on Form SR as may be required pursuant to Rule 463 of the 1933 Act
Regulations.

(j) Listing. The Company will use its best efforts to effect and maintain
the quotation of the ADSs on the NASDAQ and will file with the NASDAQ all
documents and notices required by the NASDAQ of companies that are traded on the
NASDAQ and quotations for which are reported by the NASDAQ.

(k) Restriction on Sale of Securities. During a period of 180 days from the
date of this Agreement (the "Lock-Up Period"), the Company shall not, without
the prior written consent of the Representative, (i) directly or indirectly,
dispose of (including without limitation, issue, agree to issue, offer, pledge,
sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase or
otherwise transfer or dispose of, directly or indirectly), any Common Shares or
ADSs or any security that constitutes the right to receive Common Shares or ADSs
or any securities convertible into or exercisable or exchangeable for or
repayable with Common Shares or ADSs (collectively, the "Lock-Up Securities") or
file any registration statement under the 1933 Act with respect to any of the
foregoing or (ii) enter into any swap agreement or any other agreement or any
transaction that transfers, in whole or in part, directly or indirectly, the
economic consequences of ownership of the Common Shares or ADSs, whether any
such swap agreement or other agreement or transaction described in clause (i) or
(ii) above is to be settled by delivery of Common Shares or ADSs or such other
securities, in cash or otherwise. The foregoing shall not apply to (A) the
Common Shares or ADSs to be sold hereunder, (B) the transactions by the Company
with the prior written consent of the Representative, (C) any issuance of share
options or restricted shares to the Company's directors, officers and employees
in accordance with and in the amounts specified in the Company's existing share
option plans referred to in the General Disclosure Package and the Prospectus;
and (D) the issuance of the Common Shares or ADSs upon the exercise of employee
share options, restricted shares or other options or warrants to purchase Common
Shares outstanding on the date of the Prospectus and referred to in the General
Disclosure Package and the Prospectus; provided that, with respect to clause (D)
above, the holders of such Common Shares or ADSs shall not be permitted to
transfer such Common Shares or ADSs during such 180-day period. Notwithstanding
the foregoing, if (1) during the last 17 days of the Lock-Up Period, the Company
issues an earnings release or material news or a material event relating to the
Company occurs or (2) prior to the expiration of the Lock-Up Period, the Company
announces that it will release earnings results or becomes aware that material
news or a material event will occur during the 16-day period beginning on the
last day of the Lock-Up Period, the restrictions imposed by this subsection (k)
shall continue to apply until the expiration of the 18-day period beginning on
the issuance of the earnings release or the occurrence of the material news or
material event, as applicable, unless the Representative waives, in writing,
such extension.

(l) Other Documents. The Company will furnish to the Depositary and to
holders of ADRs, directly or through the Depositary, such reports, documents and
other information described in the Prospectus under the caption "Description of
American Depositary Shares" in accordance with the procedures stated thereunder.

27


(m) Reporting Requirements. The Company, during the period when any
Prospectus is required to be delivered under the 1933 Act or the 1934 Act, will
file all documents required to be filed with the Commission pursuant to the 1934
Act within the time periods required by the 1934 Act and the 1934 Act
Regulations.

(n) Compliance with FINRA Rules. The Company hereby agrees that it will
ensure that the Reserved Securities will be restricted as required by FINRA or
the rules, regulations and interpretations of FINRA from sale, transfer,
assignment, pledge or hypothecation for a period of three months following the
date of this Agreement. The Underwriters will notify the Company as to which
persons will need to be so restricted. At the request of the Underwriters, the
Company will direct the transfer agent to place a stop transfer restriction upon
such securities for such period of time. Should the Company release, or seek to
release, from such restrictions any of the Reserved Securities, the Company
agrees to reimburse the Underwriters for any reasonable expenses (including,
without limitation, legal expenses) they incur in connection with such release.

(o) Issuer Free Writing Prospectuses. The Company represents and agrees
that, unless it obtains the prior consent of the Representative, and each
Underwriter represents and agrees that, unless it obtains the prior consent of
the Company and the Representative, it has not made and will not make any offer
relating to the Securities that would constitute an "issuer free writing
prospectus," as defined in Rule 433, or that would otherwise constitute a "free
writing prospectus," as defined in Rule 405, required to be filed with the
Commission. Any such free writing prospectus consented to by the Company and the
Representative is hereinafter referred to as a "Permitted Free Writing
Prospectus." The Company represents that it has treated or agrees that it will
treat each Permitted Free Writing Prospectus as an "issuer free writing
prospectus," as defined in Rule 433, and has complied and will comply with the
requirements of Rule 433 applicable to any Permitted Free Writing Prospectus,
including timely filing with the Commission where required, legending and record
keeping.

(p) Submission of Documents. The Company agrees to file with FINRA, the
NASDAQ, the Commission and any other governmental or regulatory agency,
authority or instrumentality in the Cayman Islands, the United States and the
People's Republic of China, as may be required, such reports, documents,
agreements and other information which the Company may from time to time be
required to file, including those relating to the implementation and payment of
dividends or other distributions on the Securities.

(q) Investment Company Act. The Company will not be or become, within two
years of the Closing Time, an "investment company" as defined in the 1940 Act.

(r) Stabilization and Manipulation. The Company agrees not to (and to use
its best efforts to cause its affiliates not to) take, directly or indirectly,
any action which is designed to or which constitutes or that might reasonably be
expected to cause or result in stabilization or manipulation of the price of any
security of the Company.

(s) Deposit of Common Shares. Prior to the Closing Time and each Date of
Delivery, the Company will deposit or cause to be deposited Common Shares with
the Depositary in accordance with the provisions of the Deposit Agreement so
that the ADRs evidencing the ADSs

28


to be delivered by such party to the Underwriters at such Closing Time or Date
of Delivery are executed, countersigned and issued by the Depositary against
receipt of such Common Shares and delivered to the Underwriters at such Closing
Time or Date of Delivery.

(t) Annual Reports. The Company agrees to furnish to its shareholders as
soon as practicable after the end of each fiscal year an annual report in
English, including a review of operations and audited consolidated financial
statements and a report thereon prepared by the Company's independent
accountants in accordance with US GAAP of net income (loss), shareholders'
equity and, as necessary, other selected balance sheet and statement of
operations items in such financial statements.

(u) Liabilities and Agreements Prior to the Closing Time. The Company
agrees that except as disclosed in the Prospectus and except for those which are
not material to the Company, prior to the Closing Time, it will not incur any
liabilities or enter into any material agreements (except in the ordinary course
of its business) without the prior written consent of the Representative.

(v) Cayman Islands Matters. The Company agrees that (i) it will not attempt
to avoid any judgment obtained by it or denied to it in a court of competent
jurisdiction outside the Cayman Islands, (ii) following the consummation of the
Offering, it will use its best efforts to obtain and maintain all approvals
required in the Cayman Islands to pay and remit outside the Cayman Islands all
dividends declared by the Company and payable on the Common Shares, and (iii) it
will use its best efforts to obtain and maintain all approvals required in the
Cayman Islands for the Company to acquire sufficient foreign exchange for the
payment of dividends and all other relevant purposes.

(w) Deposit Agreement. The Company agrees to abide by the covenants set
forth in the Deposit Agreement.

(x) Internal Controls Improvement. The Company has reviewed the management
letter of KPMG, the independent registered public accounting firm of the
Company, dated September 4, 2007, issued by KPMG in connection with its audits
of the financial statements of the Company as of and for the fiscal years ended
March 31, 2006 and 2007 and the Company understands the content thereof,
including the material weaknesses in and other deficiencies relating to the
Company's internal controls cited therein. The Company has taken and will
continue to take all actions necessary to address and remediate such material
weaknesses in and other deficiencies relating to the Company's internal
controls, including hiring additional staff, training new and existing staff and
augmenting the Company's financial information technology systems.

(y) D&O Insurance. Prior to the Closing Time, the Company will purchase
insurance covering its directors and officers for liabilities or losses arising
in connection with this offering, including, without limitation, liabilities or
losses arising under the 1933 Act, the 1934 Act, the 1933 Act Regulations and
the 1934 Act Regulations.

(z) Transfer Restrictions. The Company shall at all times maintain transfer
restrictions (including the inclusion of legends in share certificates, as may
be required) with respect to the

29


Company's Common Shares which are subject to transfer restrictions pursuant to
this Agreement and the lock-up agreements referred to in Section 5(m) hereof and
shall ensure compliance with such restrictions on the transfer of restricted
Common Shares. The Company shall retain all share certificates which are by
their terms subject to transfer restrictions until such time as such transfer
restrictions are no longer applicable to such securities.

(aa) Sarbanes-Oxley Act. The Company will use its best efforts to comply
with the Sarbanes-Oxley Act, and will use its best efforts to cause the
Company's directors and officers, in their capacities as such, to comply with
the Sarbanes-Oxley Act.

(bb) OFAC. The Company will not directly or indirectly use the proceeds of
the Securities offered hereunder, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person
or entity, for the purpose of financing the activities of any person currently
subject to any U.S. sanctions administered by OFAC.

SECTION 4. Payment of Expenses.

(a) Expenses. The Company will pay or cause to be paid all expenses
incident to the performance of its obligations under this Agreement, including
(i) the preparation, printing and filing of the Registration Statement
(including financial statements and exhibits) as originally filed and of each
amendment thereto, of the ADR Registration Statement and of each amendment
thereto and of the Form 8-A Registration Statement and of each amendment
thereto, each preliminary prospectus and the Prospectus and any amendments or
supplements thereto, and any costs associated with the electronic delivery of
any of the foregoing by the Underwriters to investors, (ii) the preparation,
printing and delivery to the Underwriters of this Agreement, any Agreement among
Underwriters and such other documents as may be required in connection with the
offering, purchase, sale, issuance or delivery of the Securities, (iii) the
preparation, issuance and delivery of the certificates for the Securities to the
Underwriters, including any stock or other transfer taxes and any stamp or other
duties payable upon the sale, issuance or delivery of the Securities to the
Underwriters, (iv) the delivery of the Common Shares represented by the ADSs to
the Depositary, (v) the fees and disbursements of the Company's counsels,
accountants and other advisors, (vi) the filing fees in connection with the
qualification of the Securities under securities laws in accordance with the
provisions of Section 3(f) hereof, including filing fees and the fees and
disbursements of counsel for the Underwriters in connection therewith and in
connection with the preparation of any "Blue Sky Survey" and any supplement
thereto, (vii) the printing and delivery to the Underwriters of copies of each
preliminary prospectus, any Permitted Free Writing Prospectus and of the
Prospectus and any amendments or supplements thereto and any costs associated
with electronic delivery of any of the foregoing by the Underwriters to
investors, (viii) the preparation, printing and delivery to the Underwriters of
copies of any "Blue Sky Survey" and any supplement thereto, (ix) the fees and
expenses of the Depositary, any transfer agent or registrar, and each custodian,
if any, for the Securities, (x) the costs and expenses of the Company relating
to investor presentations on any "road show" undertaken in connection with the
marketing of the Securities, including without limitation, expenses associated
with the production of road show slides and graphics, fees and expenses of any
consultants engaged in connection with the road show presentations, travel and
lodging expenses of the representatives and officers of the Company and any such
consultants, and the cost of aircraft and other transportation chartered in
connection with the road show, (xi)

30


the fees and expenses incurred in connection with the quotation of the ADSs on
NASDAQ, (xii) the filing fees incidental to the review by FINRA of the terms of
the sale of the Securities, (xiii) the costs and expenses associated with
complying with the provisions of Section 3(e) hereof and (xiv) all costs and
expenses of the Underwriters, including the fees and disbursements of counsel
for the Underwriters, in connection with matters related to the Reserved
Securities which are designated by the Company for sale to affiliates and
associates of the Company, and (xv) the costs and expenses (including without
limitation any damages or other amounts payable in connection with legal or
contractual liability) associated with the reforming of any contracts for sale
of the Securities made by the Underwriter caused by a breach of the
representation contained in the third paragraph of Section 1(a)(i).

(b) Termination of Agreement. If this Agreement is terminated by the
Representative in accordance with the provisions of Section 5, Section 9(a) or
Section 11 hereof, the Company shall reimburse the Underwriters for all of their
accountable out-of-pocket expenses actually incurred, including the reasonable
fees and disbursements of counsel for the Underwriters.

(c) Expenses. For the avoidance of doubt, this Section 4 supersedes all
prior agreements between the parties hereto regarding the allocation and payment
of expenses.

SECTION 5. Conditions of the Underwriters' Obligations. The obligations of
the several Underwriters hereunder, as to the ADSs to be delivered at the
Closing Time and each Date of Delivery, are subject to the accuracy of the
representations and warranties of the Company contained in Section 1 hereof or
in certificates of any officer of the Company and the Group Entities delivered
pursuant to the provisions hereof, to the performance by the Company of its
covenants and other obligations hereunder, and to the following further
conditions.

(a) Effectiveness of Registration Statement. The Registration Statement,
including any Rule 462(b) Registration Statement, the ADR Registration Statement
and the Form 8-A Registration Statement, shall have become effective and at such
Date of Delivery no stop order suspending the effectiveness of the Registration
Statement, the ADR Registration Statement or the Form 8-A Registration Statement
shall have been issued under the 1933 Act or the 1934 Act or proceedings
therefor initiated or threatened by the Commission, and any request on the part
of the Commission for additional information shall have been complied with to
the reasonable satisfaction of counsel to the Underwriters. A prospectus
containing the Rule 430A Information shall have been filed with the Commission
in accordance with Rule 424(b) without reliance on Rule 424(b)(8) or a
post-effective amendment providing such information shall have been filed and
declared effective in accordance with the requirements of Rule 430A.

(b) Opinion of Cayman Islands Counsel for Company. At Closing Time, the
Representative shall have received the opinion, dated as of such Closing Time,
of Conyers Dill & Pearman, Cayman Islands counsel for the Company, in form and
substance satisfactory to counsel for the Underwriters, together with signed or
reproduced copies of such letter for each of the other Underwriters, to the
effect set forth in Exhibit A hereto and to such further effect as the
Underwriters may reasonably request.

(c) Opinion of British Virgin Islands Counsel for Company. At Closing Time,
the Representative shall have received the opinion, dated as of such Closing
Time, of Conyers Dill

31


& Pearman, British Virgin Islands counsel for the Company, in form and substance
satisfactory to counsel for the Underwriters, together with signed or reproduced
copies of such letter for each of the other Underwriters, to the effect set
forth in Exhibit B hereto and to such further effect as the Underwriters may
reasonably request.

(d) Opinion of Special U.S. Counsel for Company. At Closing Time, the
Representative shall have received the opinion, dated as of such Closing Time,
of O'Melveny & Myers LLP, special U.S. counsel for the Company, in form and
substance satisfactory to counsel for the Underwriters, together with signed or
reproduced copies of such opinion for each of the other Underwriters, to the
effect set forth in Exhibit C hereto and to such further effect as the
Underwriters may reasonably request.

(e) Opinion of Special PRC Counsel for Company. At Closing Time, the
Representative shall have received the opinion, dated as of such Closing Time,
of Jincheng & Tongda Law Firm, special PRC counsel for the Company, in form and
substance satisfactory to counsel for the Underwriters, together with signed or
reproduced copies of such letter for each of the other Underwriters, to the
effect set forth in Exhibit D hereto and to such further effect as the
Underwriters may reasonably request.

(f) Opinion of U.S. Counsel for Underwriters. At Closing Time, the
Representative shall have received the favorable opinion, dated as of such
Closing Time, of Simpson Thacher & Bartlett LLP, U.S. counsel for the
Underwriters, in form and substance satisfactory to the Representative, together
with signed or reproduced copies of such letter for each of the other
Underwriters.

(g) Opinion of Special PRC Counsel for Underwriters. At Closing Time, the
Representative shall have received the favorable opinion, dated as of such
Closing Time, of Commerce & Finance Law Offices, special PRC counsel for the
Underwriters, in form and substance satisfactory to the Representative, together
with signed or reproduced copies of such letter for each of the other
Underwriters.

(h) Opinion of Counsel for Depositary. At Closing Time, the Representative
shall have received the favorable opinion, dated as of such Closing Time, of
Patterson Belknap Webb & Tyler LLP, counsel for the Depositary, in form and
substance satisfactory to counsel for the Underwriters, together with signed or
reproduced copies of such letter for each of the other Underwriters to the
effect set forth in Exhibit E hereto and to such further effect as the
Underwriters may reasonably request.

(i) Officers' Certificate. At Closing Time, there shall not have been,
since the date hereof or since the respective dates as of which information is
given in the Prospectus, any material adverse change in the condition, financial
or otherwise, or in the earnings, business affairs or business prospects of the
Company and the Group Entities taken as a whole, whether or not arising in the
ordinary course of business, and the Representative shall have received a
certificate of the chief executive officer and chief financial officer of the
Company, dated as of the Closing Time, to the effect that (i) there has been no
such material adverse change, (ii) the representations and warranties in Section
1(a) hereof are true and correct with the same force and effect as though
expressly made at and as of such Closing Time, (iii) the Company has complied

32


with all agreements and satisfied all conditions contained herein on its part to
be performed or satisfied at or prior to the Closing Time, and (iv) no stop
order suspending the effectiveness of the Registration Statement, the ADR
Registration Statement or the Form 8-A Registration Statement has been issued
and no proceedings for that purpose have been instituted or are pending or, to
such officers' knowledge, are contemplated by the Commission.

(j) Accountant's Comfort Letter. At the time of the execution of this
Agreement, the Representative shall have received from KPMG a letter dated such
date, in form and substance satisfactory to the Representative and KPMG,
together with signed or reproduced copies of such letter for each of the other
Underwriters containing statements and information of the type ordinarily
included in accountants' "comfort letters" to underwriters with respect to the
financial statements and certain financial information contained in the
Registration Statement and the Prospectus.

(k) Bring-down Comfort Letter. At Closing Time, the Representative shall
have received from KPMG a letter, dated as of such Closing Time, to the effect
that they reaffirm the statements made in the letter furnished pursuant to
subsection (j) of this section, except that the specified date referred to shall
be a date not more than five business days prior to such Closing Time.

(l) Approval of Listing. At Closing Time, the ADSs shall have been approved
for inclusion in the NASDAQ, subject only to official notice of approval.

(m) No Objection by FINRA. At or prior to Closing Time, FINRA shall have
confirmed that it has not raised any objection with respect to the fairness and
reasonableness of the underwriting terms and arrangements.

(n) Lock-up Agreement. At the date of this Agreement, the Representative
shall have received a lock-up agreement substantially in the form of Exhibit F
hereto duly signed by each of the directors, executive officers and shareholders
of the Company, the names of which or whom are listed on Schedule C hereto.

(o) Conditions to Purchase of Option Securities. In the event that the
Underwriters exercise their option provided in Section 2(b) hereof to purchase
all or any portion of the Option Securities, the representations and warranties
of the Company contained herein and the statements in any certificates furnished
by any of the Company and the Group Entities hereunder shall be true and correct
as of each Date of Delivery and, at the relevant Date of Delivery, the
Representative shall have received:

(i) Officers' Certificate. A certificate, dated such Date of Delivery,
of the chief executive officer and chief financial officer of the Company
confirming that the certificate delivered at the Closing Time pursuant to
Section 5(i) hereof remains true and correct as of such Date of Delivery.

(ii) Opinion of Cayman Islands Counsel for Company. The favorable
opinion of Conyers Dill & Pearman, Cayman Islands counsel for the Company,
in form and substance satisfactory to counsel for the Underwriters, dated
such Date of Delivery,

33

relating to the Option Securities to be purchased on such Date of Delivery
and otherwise to the same effect as the opinion required by Section 5(b)
hereof.

(iii) Opinion of British Virgin Islands Counsel for Company. The
favorable opinion of Conyers Dill & Pearman, British Virgin Islands counsel
for the Company, in form and substance satisfactory to counsel for the
Underwriters, dated such Date of Delivery, relating to the Option
Securities to be purchased on such Date of Delivery and otherwise to the
same effect as the opinion required by Section 5(c) hereof.

(iv) Opinion of Special U.S. Counsel for Company. The opinion of
O'Melveny & Myers LLP, special U.S. counsel for the Company, in form and
substance satisfactory to counsel for the Underwriters, dated such Date of
Delivery, relating to the Option Securities to be purchased on such Date of
Delivery and otherwise to the same effect as the opinion required by
Section 5(d) hereof.

(v) Opinion of Special PRC Counsel for Company. The favorable opinion
of Jincheng & Tongda Law Firm, special PRC counsel for the Company, in form
and substance satisfactory to counsel for the Underwriters, dated such Date
of Delivery, relating to the Option Securities to be purchased on such Date
of Delivery and otherwise to the same effect as the opinion required by
Section 5(e) hereof.

(vi) Opinion of U.S. Counsel for Underwriters. The favorable opinion
of Simpson Thacher & Bartlett LLP, U.S. counsel for the Underwriters, in
form and substance satisfactory to the Underwriters, dated such Date of
Delivery, relating to the Option Securities to be purchased on such Date of
Delivery and otherwise to the same effect as the opinion required by
Section 5(f) hereof.

(vii) Opinion of Special PRC Counsel for Underwriters. The favorable
opinion of Commerce & Finance Law Offices, special PRC counsel for the
Underwriters, in form and substance satisfactory to the Underwriters, dated
such Date of Delivery, relating to the Option Securities to be purchased on
such Date of Delivery and otherwise to the same effect as the opinion
required by Section 5(g) hereof.

(viii) Opinion of Counsel for Depositary. The favorable opinion of
Patterson Belknap Webb & Tyler LLP, counsel for the Depositary, in form and
substance satisfactory to counsel for the Underwriters, dated such Date of
Delivery, relating to the Option Securities to be purchased on such Date of
Delivery and otherwise to the same effect as the opinion required by
Section 5(h) hereof.

(ix) Bring-down Comfort Letter. A letter from KPMG, in form and
substance satisfactory to the Representative dated such Date of Delivery,
substantially in the same form and substance as the letter furnished to the
Underwriters pursuant to Section 5(k) hereof, except that the "specified
date" in the letter furnished pursuant to this paragraph shall be a date
not more than five business days prior to such Date of Delivery.

(p) Additional Documents. At Closing Time and each Date of Delivery,
counsel for the Underwriters shall have been furnished with such documents and
opinions as they may require for the purpose of enabling them to pass upon the
issuance and sale of the Securities as herein contemplated, or in order to
evidence the accuracy of any of the representations or warranties, or the
fulfillment of any of the conditions, herein contained; and all proceedings
taken by the Company in connection with the issuance and sale of the Securities
as herein contemplated shall be satisfactory in form and substance to the
Representative and counsel for the Underwriters.

34


(q) Termination of Agreement. If any condition specified in this Section
shall not have been fulfilled when and as required to be fulfilled, this
Agreement, the Deposit Agreement, or, in the case of any condition to the
purchase of Option Securities at a Date of Delivery which is after the Closing
Time, the obligations of the Underwriters to purchase the relevant Option
Securities, may be terminated by the Representative by notice to the Company at
any time at or prior to the Closing Time or such Date of Delivery, as the case
may be, and such termination shall be without liability of any party to any
other party except as provided in Section 4 and except that Sections 1, 6, 7, 8,
13, 14 and 15 shall survive any such termination and remain in full force and
effect.

SECTION 6. Indemnification.

(a) Indemnification of the Underwriters. The Company agrees to indemnify
and hold harmless each Underwriter, its affiliates, as such term is defined in
Rule 501(b) under the 1933 Act (each, an "Affiliate"), its selling agents and
each person, if any, who controls any Underwriter within the meaning of Section
15 of the 1933 Act or Section 20 of the 1934 Act as follows:

(i) against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, arising out of any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement
(or any amendment thereto), including the Rule 430A Information, if
applicable, the ADR Registration Statement or the Form 8-A Registration
Statement or the omission or alleged omission therefrom of a material fact
required to be stated therein or necessary to make the statements therein
not misleading or arising out of any untrue statement or alleged untrue
statement of a material fact included in any preliminary prospectus, any
Issuer Free Writing Prospectus or the Prospectus (or any amendment or
supplement thereto), or the omission or alleged omission therefrom of a
material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading;

(ii) against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, arising out of (A) the violation of any applicable
laws or regulations of foreign jurisdictions where Reserved Securities have
been offered and (B) any untrue statement or alleged untrue statement of a
material fact included in the supplement or prospectus wrapper material
distributed in jurisdictions outside the United States in connection with
the reservation and sale of the Reserved Securities to eligible directors,
officers, employees and associates of the Company or the omission or
alleged omission therefrom of a material fact necessary to make the
statements therein, when considered in conjunction with the Prospectus or
preliminary prospectus, not misleading;

(iii) against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, to the extent of the aggregate amount paid in
settlement of any litigation, or any investigation or proceeding by any
governmental agency or body, commenced or threatened, or of any claim
whatsoever based upon any such untrue statement or omission, or any such
alleged untrue statement or omission or in connection with any violation of
the nature referred to in Section 6(a)(ii)(A) hereof; provided that
(subject to Section 6(d) below) any such settlement is effected with the
written consent of the Company; and

35


(iv) against any and all expense whatsoever, as incurred (including
the fees and disbursements of counsel chosen by the Representative),
reasonably incurred in investigating, preparing or defending against any
litigation, or any investigation or proceeding by any governmental agency
or body, commenced or threatened, or any claim whatsoever based upon any
such untrue statement or omission, or any such alleged untrue statement or
omission or in connection with any violation of the nature referred to in
Section 6(a)(ii)(A) hereof, to the extent that any such expense is not paid
under (i) or (ii) above;

provided, however, this indemnity agreement shall not apply to any loss,
liability, claim, damage or expense to the extent arising out of any untrue
statement or omission or alleged untrue statement or omission made in reliance
upon and in conformity with written information furnished to the Company by any
Underwriter through the Representative expressly for use in the Registration
Statement, the ADR Registration Statement or the Form 8-A Registration Statement
(or any amendment thereto), including the Rule 430A Information, if applicable,
or any preliminary prospectus, any Issuer Free Writing Prospectus or the
Prospectus (or any amendment or supplement thereto).

(b) Indemnification of the Company, Directors and Officers. Each
Underwriter severally agrees to indemnify and hold harmless the Company, its
directors, each of its officers who signed the Registration Statement, the ADR
Registration Statement or the Form 8-A Registration Statement, and each person,
if any, who controls the Company within the meaning of Section 15 of the 1933
Act or Section 20 of the 1934 Act, against any and all loss, liability, claim,
damage and expense described in the indemnity contained in subsection (a) of
this Section, as incurred, but only with respect to untrue statements or
omissions, or alleged untrue statements or omissions, made in the Registration
Statement, the ADR Registration Statement or the Form 8-A Registration Statement
(or any amendment thereto), including the Rule 430A Information, if applicable,
or any preliminary prospectus, any Issuer Free Writing Prospectus or the
Prospectus (or any amendment or supplement thereto) in reliance upon and in
conformity with written information furnished to the Company by such Underwriter
through the Representative expressly for use therein.

(c) Actions against Parties; Notification. Each indemnified party shall
give notice as promptly as reasonably practicable to each indemnifying party of
any action commenced against it in respect of which indemnity may be sought
hereunder, but failure to so notify an indemnifying party shall not relieve such
indemnifying party from any liability hereunder to the extent it is not
materially prejudiced as a result thereof and in any event shall not relieve it
from any liability which it may have otherwise than on account of this indemnity
agreement. In the case of parties indemnified pursuant to Section 6(a) above,
counsel to the indemnified parties shall be selected by the Representative, and,
in the case of parties indemnified pursuant to Section 6(b) above, counsel to
the indemnified parties shall be selected by the Company. An indemnifying party
may participate at its own expense in the defense of any such action; provided,
however, that counsel to the indemnifying party shall not (except with the
consent of the indemnified party) also be counsel to the indemnified party. In
no event shall the indemnifying parties be liable for fees and expenses of more
than one counsel (in addition to any local counsel) separate from their own
counsel for all indemnified parties in connection with any one action or
separate but similar or related actions in the same jurisdiction arising out of
the

36


same general allegations or circumstances. No indemnifying party shall, without
the prior written consent of the indemnified parties, settle or compromise or
consent to the entry of any judgment with respect to any litigation, or any
investigation or proceeding by any governmental agency or body, commenced or
threatened, or any claim whatsoever in respect of which indemnification or
contribution could be sought under this Section 6 or Section 7 hereof (whether
or not the indemnified parties are actual or potential parties thereto), unless
such settlement, compromise or consent (i) includes an unconditional release of
each indemnified party from all liability arising out of such litigation,
investigation, proceeding or claim and (ii) does not include a statement as to
or an admission of fault, culpability or a failure to act by or on behalf of any
indemnified party.

(d) Settlement without Consent if Failure to Reimburse. If at any time an
indemnified party shall have requested an indemnifying party to reimburse the
indemnified party for fees and expenses of counsel, such indemnifying party
agrees that it shall be liable for any settlement of the nature contemplated by
Section 6(a)(iii) or settlement of any claim in connection with any violation
referred to in Section 6(e) effected without its written consent if (i) such
settlement is entered into more than 45 days after receipt by such indemnifying
party of the aforesaid request, (ii) such indemnifying party shall have received
notice of the terms of such settlement at least 30 days prior to such settlement
being entered into and (iii) such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request prior to the date of such
settlement.

(e) Indemnification for Reserved Securities. In connection with the offer
and sale of the Reserved Securities, the Company agrees, promptly upon a request
in writing, to indemnify and hold harmless the Underwriters from and against any
and all losses, liabilities, claims, damages and expenses incurred by them (i)
as a result of the failure of an Directed Share Participant to pay for and
accept delivery of Reserved Securities which, by the end of the first business
day following the date of this Agreement, were subject to a properly confirmed
agreement to purchase; or (ii) related to, or arising out of or in connection
with, the offering of Reserved Securities, other than, in the case of this
clause (ii), losses, liabilities, claims, damages and expenses incurred by the
Underwriters that are finally and judicially determined by a court of competent
jurisdiction to have resulted from the gross negligence or willful misconduct of
the Underwriters.

SECTION 7. Contribution. If the indemnification provided for in Section 6
hereof is for any reason unavailable to or insufficient to hold harmless an
indemnified party in respect of any losses, liabilities, claims, damages or
expenses referred to therein, then each indemnifying party shall contribute to
the aggregate amount of such losses, liabilities, claims, damages and expenses
incurred by such indemnified party, as incurred, (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one
hand and the Underwriters on the other hand from the offering of the Securities
pursuant to this Agreement or (ii) if the allocation provided by clause (i) is
not permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause (i) above but also the
relative fault of the Company on the one hand and the Underwriters on the other
hand, respectively, in connection with the statements or omissions, or in
connection with any violation of the nature referred to in Section 6(a)(ii)(A)
hereof, that resulted in such losses, liabilities, claims, damages or expenses,
as well as any other relevant equitable considerations.

37


The relative benefits received by the Company on the one hand and the
Underwriters on the other hand in connection with the offering of the Securities
pursuant to this Agreement shall be deemed to be in the same respective
proportions as the total net proceeds from the offering of the Securities
pursuant to this Agreement (before deducting expenses) received by the Company
and the total underwriting discount received by the Underwriters, in each case
as set forth on the cover of the Prospectus bear to the aggregate initial public
offering price of the Securities as set forth on such cover.

The relative fault of the Company on the one hand and the Underwriters on
the other hand shall be determined by reference to, among other things, whether
any such untrue or alleged untrue statement of a material fact or omission or
alleged omission to state a material fact relates to information supplied by the
Company or by the Underwriters and the parties' relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission or any violation of the nature referred in on Section 6(a)(ii)(A)
hereof.

The Company and the Underwriters agree that it would not be just and
equitable if contribution pursuant to this Section 7 were determined by pro rata
allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to above in this Section 7. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an
indemnified party and referred to above in this Section 7 shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation, or any
investigation or proceeding by any governmental agency or body, commenced or
threatened, or any claim whatsoever based upon any such untrue or alleged untrue
statement or omission or alleged omission.

Notwithstanding the provisions of this Section 7, no Underwriter shall be
required to contribute any amount in excess of the amount by which the total
price at which the Securities underwritten by it and distributed to the public
were offered to the public exceeds the amount of any damages which such
Underwriter has otherwise been required to pay by reason of any such untrue or
alleged untrue statement or omission or alleged omission.

No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the 1933 Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.

For purposes of this Section 7, each person, if any, who controls an
Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act and each Underwriter's Affiliates and selling agents shall have the
same rights to contribution as such Underwriter, and each director of the
Company, each officer of the Company who signed the Registration Statement, the
ADR Registration Statement and the Form 8-A Registration Statement, and each
person, if any, who controls the Company within the meaning of Section 15 of the
1933 Act or Section 20 of the 1934 Act shall have the same rights to
contribution as the Company. The Underwriters' respective obligations to
contribute pursuant to this Section 7 are several in proportion to the number of
Initial Securities set forth opposite their respective names in Schedule A
hereto and not joint.

38

SECTION 8. Representations, Warranties and Agreements to Survive Delivery.
All representations, warranties and agreements contained in this Agreement or in
certificates of officers of any of the Company and the Group Entities submitted
pursuant hereto shall remain operative and in full force and effect, regardless
of any investigation made by or on behalf of any Underwriter or any controlling
person, or by or on behalf of the Company, and shall survive delivery of the
Securities to the Underwriters.

SECTION 9. Termination of Agreement.

(a) Termination; General. The Representative may terminate this Agreement,
by notice to the Company at any time at or prior to the Closing Time (i) if
there has been, since the time of execution of this Agreement or since the
respective dates as of which information is given in the Prospectus or the
General Disclosure Package, any material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or business
prospects of any of the Company and the Group Entities, individually or in the
aggregate, whether or not arising in the ordinary course of business, or (ii) if
there has occurred any material adverse change in the financial markets in the
United States or the PRC or the international financial markets, any outbreak of
hostilities or escalation thereof or other calamity or crisis or any change or
development involving a prospective change in either U.S., Cayman Islands,
British Virgin Islands, PRC or international political, financial or economic
conditions or currency exchange rates or exchange controls, in each case the
effect of which is such as to make it, in the judgment of the Representative,
impracticable or inadvisable to market the Securities or to enforce contracts
for the sale of the Securities, or (iii) if trading in any securities of the
Company has been suspended or materially limited by the Commission, NASDAQ, or
if trading generally on the American Stock Exchange or the New York Stock
Exchange or in NASDAQ has been suspended or materially limited, or minimum or
maximum prices for trading have been fixed, or maximum ranges for prices have
been required, by any of said exchanges or by such system or by order of the
Commission, FINRA or any other governmental authority, or a material disruption
has occurred in commercial banking or securities settlement or clearance
services in the United States or with respect to Clearstream or Euroclear
systems in Europe, or (iv) if a banking moratorium has been declared by the
Cayman Islands, People's Republic of China, U.S. federal or New York
authorities.

(b) Liabilities. If this Agreement is terminated pursuant to this Section
9, such termination shall be without liability of any party to any other party
except as provided in Section 4 hereof, and provided, further, that Sections 1,
6, 7, 8, 13, 14 and 15 shall survive such termination and remain in full force
and effect.

SECTION 10. Default by One or More of the Underwriters. If one or more of
the Underwriters shall fail at the Closing Time or a Date of Delivery to
purchase the Securities which it or they are obligated to purchase under this
Agreement (the "Defaulted Securities"), the Representative shall have the right,
within 24 hours thereafter, to make arrangements for one or more of the
non-defaulting Underwriters, or any other underwriters, to purchase all, but not
less than all, of the Defaulted Securities in such amounts as may be agreed upon
and upon the terms herein set forth; if, however, the Representative shall not
have completed such arrangements within such 24-hour period, then:

39


(a) if the number of Defaulted Securities does not exceed 10% of the number
of Securities to be purchased on such date, each of the non-defaulting
Underwriters shall be obligated, severally and not jointly, to purchase the full
amount thereof in the proportions that their respective underwriting obligations
hereunder bear to the underwriting obligations of all non-defaulting
Underwriters, or

(b) if the number of Defaulted Securities exceeds 10% of the number of
Securities to be purchased on such date, this Agreement or, with respect to any
Date of Delivery which occurs after the Closing Time, the obligation of the
Underwriters to purchase and of the Company to sell the Option Securities to be
purchased and sold on such Date of Delivery shall terminate without liability on
the part of any non-defaulting Underwriter.

No action taken pursuant to this Section 10 shall relieve any defaulting
Underwriter from liability in respect of its default.

In the event of any such default that does not result in a termination of
this Agreement or, in the case of a Date of Delivery that is after the Closing
Time, that does not result in a termination of the obligation of the
Underwriters to purchase and the Company to sell the relevant Option Securities,
as the case may be, either the Representative or the Company shall have the
right to postpone the Closing Time or the relevant Date of Delivery, as the case
may be, for a period not exceeding seven days in order to effect any required
changes in the Registration Statement or Prospectus or in any other documents or
arrangements. As used herein, the term "Underwriters" includes any person
substituted for an Underwriter under this Section 10.

SECTION 11. Default by the Company. If the Company shall fail at the
Closing Time or at the Date of Delivery to sell the number of Securities that it
is obligated to sell hereunder, then this Agreement shall terminate without any
liability on the part of any non-defaulting party; provided, however, that the
provisions of Sections 1, 6, 7, 8, 13, 14 and 15 shall remain in full force and
effect. No action taken pursuant to this Section 11 shall relieve the Company
from liability, if any, in respect of such default.

SECTION 12. Tax Disclosure. Notwithstanding any other provision of this
Agreement, immediately upon commencement of discussions with respect to the
transactions contemplated hereby, the Company (and each employee, representative
or other agent of the Company) may disclose to any and all persons, without
limitation of any kind, the tax treatment and tax structure of the transactions
contemplated by this Agreement and all materials of any kind (including opinions
or other tax analyses) that are provided to the Company relating to such tax
treatment and tax structure. For purposes of the foregoing, the term "tax
treatment" is the purported or claimed federal income tax treatment of the
transactions contemplated hereby, and the term "tax structure" includes any fact
that may be relevant to understanding the purported or claimed federal income
tax treatment of the transactions contemplated hereby.

SECTION 13. Waiver of Immunities. To the extent that the Company or any of
its properties, assets or revenues may have or may hereafter become entitled to,
or have attributed to the Company, any right of immunity, on the grounds of
sovereignty or otherwise, from any legal action, suit or proceeding, from the
giving of any relief in any such legal action, suit or proceeding, from setoff
or counterclaim, from the jurisdiction of any Cayman Islands, New York

40


or U.S. federal court, from service of process, from attachment upon or prior to
judgment, from attachment in aid of execution of judgment, or from execution of
judgment, or other legal process or proceeding for the giving of any relief or
for the enforcement of any judgment, in any such court in which proceedings may
at any time be commenced, with respect to the obligations and liabilities of the
Company, or any other matter under or arising out of or in connection with, the
Principal Agreements or any of them, the Company hereby irrevocably and
unconditionally waives or will waive such right to the extent permitted by law,
and agree not to plead or claim, any such immunity and consents to such relief
and enforcement.

SECTION 14. Consent to Jurisdiction; Appointment of Agent for Service of
Process.

(a) Consent to Jurisdiction. The Company, by its execution and delivery of
this Agreement, hereby irrevocably consents and submits to the nonexclusive
jurisdiction of any New York Court in personam generally and unconditionally in
respect of any such suit or proceeding.

(b) Appointment of Agent for Service of Process. The Company further, by
its execution and delivery of this Agreement, irrevocably designate, appoint and
empower CT Corporation System as its designee, appointee and authorized agent
(the "Authorized Agent") to receive for and on its behalf service of any and all
legal process, summons, notices and documents that may be served in any action,
suit or proceeding brought against the Company with respect to its obligations,
liabilities or any other matter arising out of or in connection with this
Agreement and that may be made on the Authorized Agent in accordance with legal
procedures prescribed for such courts, and it being understood that the
designation and appointment of CT Corporation System as the Authorized Agent
shall become effective immediately without any further action on the part of the
Company. The Company represents to each Underwriter that it has notified CT
Corporation System of such designation and appointment and that CT Corporation
System has accepted the same. The Company further agrees that, to the extent
permitted by law, proper service of process upon CT Corporation System (or its
successors as agent for service of process) and written notice of said service
to the Company pursuant to this Section 14, shall be deemed in every respect
effective service of process upon the Company in any such suit or proceeding. If
for any reason such designee, appointee and agent hereunder shall cease to be
available to act as such, the Company agrees to designate a new designee,
appointee and agent in The City of New York, New York on the terms and for the
purposes of this Section 14 reasonably satisfactory to the Representative. The
Company further hereby irrevocably consents and agrees to the service of any and
all legal process, summons, notices and documents in any such action, suit or
proceeding against the Company by serving a copy thereof upon the relevant agent
for service of process referred to in this Section 14 (whether or not the
appointment of such agent shall for any reason prove to be ineffective or such
agent shall accept or acknowledge such service) and by mailing copies thereof by
registered or certified air mail, postage prepaid, to the Company at the address
specified in or designated pursuant to this Agreement. The Company agrees that
the failure of any such designee, appointee and agent to give any notice of such
service to it shall not impair or affect in any way the validity of such service
or any judgment rendered in any action or proceeding based thereon. Nothing
herein shall in any way be deemed to limit the ability of the Underwriters and
the other persons referred to in Sections 6 and 7 to serve any such legal
process, summons, notices and documents in any other manner permitted by
applicable law or to obtain jurisdiction over the Company or bring actions,
suits or proceedings against the Company in such other jurisdictions, and in
such manner, as may be permitted by applicable law. The

41


Company hereby irrevocably and unconditionally waives, to the fullest extent
permitted by law, any objection that they may now or hereafter have to the
laying of venue of any of the aforesaid actions, suits or proceedings arising
out of or in connection with this Agreement brought in any New York Court and
hereby further irrevocably and unconditionally waives and agrees not to plead or
claim in any such court that any such action, suit or proceeding brought in such
court has been brought in an inconvenient forum.

SECTION 15. Judgment Currency. The Company agrees to indemnify each
Underwriter and each person, if any, who controls such Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, and each
Underwriter severally agrees to indemnify the Company, its directors, each of
its officers who signed the Registration Statement, the ADR Registration
Statement and the Form 8-A Registration Statement, and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act or Section
20 of the 1934 Act, against any loss incurred, as incurred, as a result of any
judgment being given in connection with this Agreement, the Prospectus, the
Registration Statement, the ADR Registration Statement or the Form 8-A
Registration Statement for which indemnification is provided by such person
pursuant to Section 6 of this Agreement and any such judgment or order being
paid in a currency (the "Judgment Currency") other than US dollars as a result
of any variation as between (i) the spot rate of exchange in New York at which
the Judgment Currency would have been convertible into US dollars as of the date
such judgment or order is entered, and (ii) the spot rate of exchange at which
the indemnified party is first able to purchase US dollars with the amount of
the Judgment Currency actually received by the indemnified party. If,
alternatively, the indemnified party receives a profit as a result of such
currency conversion, it will return any such profits to the indemnifying party
(after taking into account any taxes or other costs arising in connection with
such conversion and repayment). The foregoing indemnity shall constitute a
separate and independent, several and not joint, obligation of the Company and
the Underwriters and shall continue in full force and effect notwithstanding any
such judgment or order as aforesaid. The term "spot rate of exchange" shall
include any premiums and costs of exchange payable in connection with the
purchase of, or conversion into, the relevant currency.

SECTION 16. Notices. All notices and other communications hereunder shall
be in writing and shall be deemed to have been duly given if mailed or
transmitted by any standard form of telecommunication. Notices to the
Underwriters shall be directed to the Representative care of Merrill Lynch,
Pierce, Fenner & Smith Incorporated, 4 World Financial Center, 250 Vesey Street,
New York, New York 10080, attention of Equity Capital Markets; and notices to
the Company shall be directed to it at 8th Floor, East Tower, 6 Gongyuan West
Street, Jian Guo Men Nei, Beijing 100005, People's Republic of China, attention:
Carl Yeung, Chief Financial Officer.

SECTION 17. No Advisory or Fiduciary Relationship Notices. The Company
acknowledges and agrees that (a) the purchase and sale of the Securities
pursuant to this Agreement, including the determination of the public offering
price of the Securities and any related discounts and commissions, is an
arm's-length commercial transaction between the Company, on the one hand, and
the several Underwriters, on the other hand, (b) in connection with the offering
contemplated hereby and the process leading to such transaction each Underwriter
is and has been acting solely as a principal and is not the agent or fiduciary
of the Company, or its respective stockholders, creditors, employees or any
other party, (c) no

42


Underwriter has assumed or will assume an advisory or fiduciary responsibility
in favor of the Company with respect to the offering contemplated hereby or the
process leading thereto (irrespective of whether such Underwriter has advised or
is currently advising the Company on other matters) and no Underwriter has any
obligation to the Company with respect to the offering contemplated hereby
except the obligations expressly set forth in this Agreement, (d) the
Underwriters and their respective affiliates may be engaged in a broad range of
transactions that involve interests that differ from those of the Company, and
(e) the Underwriters have not provided any legal, accounting, regulatory or tax
advice with respect to the offering contemplated hereby and the Company has
consulted its own respective legal, accounting, regulatory and tax advisors to
the extent it deemed appropriate.

SECTION 18. Parties. This Agreement shall inure to the benefit of and be
binding upon the Underwriters, the Company and their respective successors.
Nothing expressed or mentioned in this Agreement is intended or shall be
construed to give any person, firm or corporation, other than the Underwriters,
the Company and their respective successors and the controlling persons and
officers and directors referred to in Sections 6 and 7 and their heirs and legal
representatives, any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision herein contained. This Agreement and
all conditions and provisions hereof are intended to be for the sole and
exclusive benefit of the Underwriters, the Company and their respective
successors, and said controlling persons and officers and directors and their
heirs and legal representatives, and for the benefit of no other person, firm or
corporation. No purchaser of Securities from any Underwriter shall be deemed to
be a successor by reason merely of such purchase.

SECTION 19. GOVERNING LAW AND TIME. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EXCEPT AS MAY BE
OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.

SECTION 20. Effect of Headings. The Section headings herein and the Table
of Contents are for convenience only and shall not affect the construction
hereof.

SECTION 21. Definitions. For purposes of this Agreement, (a) "business day"
means any day other than Saturday or Sunday that is not a day on which banking
institutions in New York are generally authorized or obligated by law or
executive order to close and (b) "subsidiary" has the meaning set forth in Rule
405 under the 1933 Act Regulations.

SECTION 22. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all
counterparts shall together constitute one and the same Agreement.

43


If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Company a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement among
the Underwriters and the Company in accordance with its terms.

Very truly yours,

ATA INC.



By:
--------------------------------
Name:
Title:




CONFIRMED AND ACCEPTED,
as of the date first above written:

MERRILL LYNCH, PIERCE, FENNER & SMITH
INCORPORATED


By:
--------------------------------------
Authorized Signatory

For themselves and as Representative of
the other Underwriters named in
Schedule A hereto
Schedule A

LIST OF UNDERWRITERS